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Funksjonell bedring etter hjerneslag 
Undersøkelse og behandling med fokus på motorisk funksjon 
 
 
Hjerneslag er en av våre største og alvorligste folkesykdommer og antall personer 
som får hjerneslag vil øke i de kommende år. Dette vil få store konsekvenser for 
personene som rammes, deres familie, helsevesenet og samfunnet. Lammelser er det 
vanligste utfallet etter hjerneslag og problemer med å bevege seg fører gjerne til 
redusert livskvalitet. Som en følge av dette blir det lagt stor vekt på fysioterapi og 
motorisk trening ved rehabilitering av pasienter med akutt hjerneslag.  
 
Det overordnede formålet med denne avhandlingen var å øke kunnskapen om 
motorisk bedring etter hjerneslag ved å evaluere effekten av to ulike 
behandlingsformer sammenlignet med den standard behandling som i dag gis til disse 
pasientene. Det var også et mål å undersøke hva som skjer med hjernens aktivering 
hos pasienter med akutt hjerneslag som behandles i en vitenskaplig basert slagenhet. 
 
En randomisert og kontroller studie ble gjennomført for å evaluere effekten av tidlig 
støttet utskriving for pasienter bosatt i Malvik, Melhus og Klæbu kommune som var 
innlagt ved Slagenheten ved St. Olavs Hospital. Sekstito pasienter ble inkludert og 
randomisert enten til utskriving med oppfølging av et koordinerende tverrfaglig team 
eller til standard rehabilitering. Resultatene viste ingen betydningsfulle forskjeller 
mellom gruppene med hensyn til selvhjulpenhet, balanse eller ganghastighet, men en 
forbigående mindre sosial isolasjon i gruppen som fikk oppfølging av det tverrfaglige 
teamet. I studien fant man også en sterk sammenheng mellom alvorlige lammelser i 
benet ved innleggelse og redusert balanse ett år senere.  
 
En annen randomisert og kontrollert studie ble gjennomført for å evaluere effekten og 
gjennomførbarheten av trening med begrenset bruk av frisk side for pasienter med 
subakutt og kronisk hjerneslag. Tretti pasienter ble inkludert og randomisert enten til 
ti dager intensiv trening av den affiserte hånden kombinert med en vott på den friske 
hånden, eller til en kontrollgruppe som fikk standard rehabilitering. Alle pasientene 
tolererte den intensive treningen. Behandlingsgruppen oppnådde en større bedring i 
den affiserte armen sammenlignet med kontrollgruppen umiddelbart etter at 
behandlingen var avsluttet. Seks måneder senere var det imidlertid ingen forskjell 
mellom gruppene lenger.  
 
Til slutt ble det gjennomført en studie for å undersøke hvilke endringer som skjer i 
hjernen etter hjerneslag hos pasienter som behandles med tidlig mobilisering i en 
vitenskaplig basert slagenhet. Tolv pasienter med hjerneinfarkt ble inkludert og 
undersøkt med funksjonell magnetresonanstomografi (MRI) og funksjonelle tester 4 – 
7 dager etter symptomdebut og 3 måneder senere. Alle pasientene, unntatt en, hadde 
fullstendig bedring av den affiserte armen i henhold til våre kriterier. Resultatene viste 
at hjernens aktivering allerede i tidlig fase var i ferd med å gjenopprette sin normale 
funksjon selv om pasientene fortsatt hadde lammelser på dette tidspunktet. Videre 
viste resultatene at de områdene i hjernen som ble aktivert tilsvarer områder som 
aktiveres under motorisk læring. Til slutt viste resultatene at pasientene tok i bruk 
tilleggsområder i den friske hjernehalvdelen for å gjenvinne god håndfunksjon. 
 
Forskningsarbeidet har vist at det er usikkert om utskriving med oppfølging av et 
koordinerende tverrfaglig team har noen betydningsfull effekt for pasienter som bor i 
Malvik, Melhus og Klæbu kommune. Videre har arbeidet vist at trening med 
begrenset bruk av frisk side fører til bedre funksjon i den affiserte armen på kort sikt 
men er sannsynligvis ikke bedre enn standard rehabilitering på lang sikt. Til slutt har 
dette arbeidet vist at pasienter som behandles i en slagenhet aktiverer områder i 
hjernen som har med motorisk læring å gjøre ved gjenopptrening av håndfunksjon. 
Dette indikerer at man i fremtiden sannsynligvis bør legge vekt på treningsmetoder 
som stimulerer denne type omorganisering i hjernen.  
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To my Grandmother Kristine, 
 
who suffered from severe stroke at the age of 70, but recovered with the help of her daily 
exercises, and who returned to her normal life including her daily walks, working in the 
garden and cycling to the grocery store. Her vitality inspired me until she died, 21 years later.  
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Summary 
 
The incidence of stroke has not changed significantly in recent decades. However, the actual 
number of strokes is likely to increase as a consequence of the increasing number of elderly 
people, creating a significant burden on the health care system, the patients and their families. 
Pareses are the most common impairment reported after stroke. Motor impairments are 
associated with reduced self-perceived health, and consequently rehabilitation after stroke has 
a strong emphasis on physiotherapy and motor training. However, more knowledge about 
motor recovery and effects of therapy is needed for further improvement of rehabilitation 
processes and of outcome for the large number of stroke victims.  
 
The overall aim of this thesis was to increase the knowledge about motor recovery after stroke 
by evaluating the effect of two different rehabilitation programmes compared to standard 
rehabilitation regimes and by investigating changes in brain activity in patients treated in 
terms of the recommended guidelines in the acute phase and during follow-up. 
 
A randomised controlled trial was performed to evaluate the effect of an early supported 
discharge (ESD) service for patients with acute stroke living in a rural community. Sixty-two 
eligible patients were included and randomised to either an ESD service or to standard follow-
up. The trial revealed no significant benefit on the Modified Rankin Scale, Barthel Index, 
Berg Balance Scale or walking speed, but significantly less isolation in the ESD group at the 
six-week follow-up. However, analysis of all cases with all assessments available showed a 
non-significant trend toward greater improvement in balance in the ESD group from one week 
to six weeks follow-up. The trial identified a strong association between initial severe leg 
paresis, but not with initial moderate leg paresis, and reduced balance one year after the 
stroke. There was also a strong association between initial inability to walk and reduced 
balance one year after the stroke. 
 
Another randomised controlled trial was performed to evaluate the efficacy and feasibility of 
Constraint-Induced Movement Therapy (CIMT) organised as group therapy for patients with 
subacute and chronic stroke. Thirty eligible patients were included and randomised to a CIMT 
group receiving ten days of intensive motor training of the affected arm or to a control group 
receiving standard rehabilitation. The CIMT group showed a statistically significant greater 
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improvement in motor function of the affected arm at the post-treatment assessment. 
However, this difference did not persist at six months' follow-up. There were no differences 
between the groups at any time in relation to the amount of use of the affected arm or to 
independence in activities of daily living.  
 
Finally, a longitudinal follow-up study was performed to investigate the changes in brain 
activation patterns from the acute to the chronic phases and their relationship to motor 
learning after stroke. Twelve eligible patients with acute ischaemic stroke were included and 
assessed with functional magnetic resonance imaging (fMRI) and clinical tests within one 
week after stroke and three months later. All patients, except one, had complete recovery of 
the affected arm according to our criteria. Increased activation in cerebellum, striatum, 
angular gyrus and insula was revealed in the acute phase compared to the chronic phase. The 
chronic phase demonstrated a restoration of the lateralised primary motor network, in addition 
to increased bilateral somatosensory association areas and contralesional secondary 
somatosensory areas (SII). The activation patterns are not identical but comparable to a motor 
learning process.  
 
In conclusion, this thesis shows that the ESD service did not significantly influence death or 
dependency, balance or walking speed for patients living in a rural community. However, it 
may lead to less isolation and a transient improvement in self-perceived health. The thesis 
also demonstrates that CIMT organised as group therapy is feasible and efficient in the short 
term but may not be superior to standard rehabilitation in the long term. Finally, the thesis has 
revealed that the motor network changes associated with successful motor recovery are 
comparable to changes observed in motor learning studies in healthy subjects, and also 
indicating the importance of bi- and contralesional brain activation for successful motor 
recovery after stroke. 
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1 Introduction 
 
1.1 The burden of stroke 
 
Stroke is the third most frequent cause of death, after heart disease and cancer, and a major 
cause of disability for those who survive (Statistisk sentralbyrå, 2003; Bonita et al., 1997). 
Stroke mortality is a function of the incidence (new cases per year) and case fatality 
(proportion of those who die). It varies widely in different regions of the world and depends 
on factors such as local environmental, cultural, socioeconomic and genetic variables (de 
Freitas GR et al., 2005). A population-based stroke study in Innherred in Norway in 1994-96 
reported an annual incidence of first-ever stroke to be 3.1 per 1000 in persons aged 15 years 
and older. The proportion of first-ever stroke and recurrent stroke is respectively 75% and 
25% (Ellekjaer et al., 1997). Adjusted to the Norwegian population we would expect 11 000 
first-ever strokes and 3500 recurrent strokes to occur every year for the next years (Ellekjaer 
& Selmer, 2007). In the WHO MONICA (Multinational Monitoring of Trends and 
Determinants in Cardiovascular Disease) project, the incidence of first-ever and recurrent 
stroke in Northern Sweden did not change significantly from 1985 to 1998, but the 28-day 
case-fatality declined from 20% to 11% over the 14-year period (Stegmayr & Asplund, 2003). 
There are no studies concerning incidence and case fatality trends in Norway. The overall 30-
day case fatality was reported to be 19% for first-ever strokes in the Innherred study 
(Ellekjaer et al., 1997; Ellekjaer & Selmer, 2007).  
 
The Swedish data indicates that the changes in mortality can be principally attributed to 
change in case fatality rather than change in incidence (Stegmayr & Asplund, 2003; Sarti et 
al., 2003). Plausible explanations for the reduction in case fatality include better stroke care, a 
decline in stroke severity, and newer methods for diagnosing stroke (CT and MRI) allowing 
detection of milder stroke cases (de Freitas GR et al., 2005; Sarti et al., 2003). The risk of 
stroke increases with age, and due to the increased birth rate after the Second World War, the 
number of persons above the age of 65 is expected to increase by approximately 50% between 
now and 2030, with a corresponding increase in the total numbers of stroke (Waaler, 1999). 
This implies that the burden of stroke will continue to grow, affecting increasing numbers of 
individuals, and their families, and increasing the cost to the economy. The mean cost 
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associated with each new stroke in Norway, from onset to death, is estimated at NOK 600 000 
(Fjaertoft & Indredavik, 2007).  
 
In conclusion, the expected increase in number of strokes, and the decrease in stroke 
mortality, will continue to place a significant burden on the health care system, the stroke 
patients and their families in the foreseeable future.  
 
1.2 Definition of stroke 
Stroke is defined as rapidly developed clinical signs of focal (or global1) disturbance of 
cerebral function lasting more than 24 hours (unless interrupted by surgery or death), with no 
apparent cause other than a vascular origin: it includes patients presenting clinical signs and 
symptoms suggestive of subarachnoid haemorrhage, intracerebral haemorrhage or cerebral 
ischaemic necrosis. It does not include transient cerebral ischaemia or stroke events in cases 
of blood disease (e.g. leukemia, polycythaemia vera), brain tumour or brain metastases (The 
WHO MONICA Project, 2007). 
The focal signs are: unilateral or bilateral motor impairment (including dyscoordination), 
unilateral or bilateral sensory impairment, aphasis/dysphasis (non-fluent speech), hemianopia 
(half-sided impairment of visual fields), diplopia, forced gaze (conjugate deviation), 
dysphagia of acute onset, apraxia of acute onset, ataxia of acute onset and perception deficit 
of acute onset (The WHO MONICA Project, 2007). 
Early stroke detection is possible by using the Face Arm Speech Test (FAST). FAST was 
developed in 1998 as a stroke identification instrument, and evaluates the presence or absence 
of face palsy, asymmetric arm weakness, and speech abnormalities (Harbison et al., 2003; 
Goldstein & Simel, 2005). Eighty-two percent of all stroke patients have one or more of these 
three symptoms (unpublished data from the Stroke Unit, St. Olavs Hospital, Trondheim). 
                                                 
1Global: this applies to patients with subarachnoid haemorrhage or deep coma but excluding 
coma of systemic vascular origin such as shock, Stokes-Adams syndrome or hypertensive 
encephalopathy. 
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Focusing on these three findings improves diagnostic accuracy and reliability (Goldstein & 
Simel, 2005). 
1.3 Types of stroke 
Stroke includes cerebral infarction, intracerebral haemorrhages and subarachnoidal 
haemorrhages. The infarctions make up 85% of the cases, the intracerebral haemorrhages 
12% and the subarachnoidal haemorrhages 3% of the cases admitted to hospital (Ellekjaer et 
al., 1997). The following two sections will focus on the infarctions, as they make up the 
majority of strokes. 
1.4 Classification of ischaemic stroke 
The infarctions can be classified into lacunar infarctions (LACI), total anterior circulation 
infarctions (TACI), partial anterior circulation infarctions (PACI) and posterior circulation 
infarctions (POCI), according to the Oxfordshire clinical classification (Bamford et al., 1991). 
The LACI presents with pure motor stroke, pure sensory stroke, sensorimotor stroke, or ataxic 
hemiparesis. The symptoms in TACI are a combination of new higher cerebral dysfunction, 
homonymous visual field defect, and ipsilateral motor and/or sensory deficits of at least two 
areas of the face, arm, and leg. The PACI is defined as the presence of two of the three 
components of the TACI syndrome, with higher cerebral dysfunction alone, or with a 
motor/sensory deficit more restricted than those classified as LACI. The POCI presents with 
any of the following: ipsilateral cranial nerve palsy with contralateral motor and/or sensory 
deficit, bilateral motor and/or sensory deficit, disorder of conjugate eye movement, cerebellar 
dysfunction without ipsilateral long track deficit, or isolated homonymous visual field defect 
(Bamford et al., 1991). This clinical classification has also shown to be a reasonably valid 
way of predicting the site and size of cerebral infarctions (Wardlaw et al., 1996). 
1.5 The mechanism of ischaemic stroke 
Cerebral infarction is the neurological evidence of critical reduction of cerebral blood flow in 
a circumscribed part of the brain, resulting from the sudden or gradually progressing 
occlusion of a brain artery (Hossmann, 2006). The infarction core is characterised by cell 
injury and necrosis surrounded by a region with functionally silent but structurally intact cells 
called the penumbra. The penumbra is a region of constrained blood supply in which energy 
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metabolism is preserved, and it will regain its function if the blood flow and oxygenation 
improve in time (Astrup et al., 1981).  
1.6 The purpose of this thesis 
A basic understanding of the processes of recovery after stroke and the evidence for motor 
training and follow-up services are still undetermined. The purpose of the investigation 
presented in this thesis was to increase the knowledge about this topic. Two randomised 
controlled trials and one longitudinal follow-up study were carried out to achieve this goal. In 
the first randomised trial we wanted to evaluate the effect of a multidisciplinary rehabilitation 
programme. In the second trial we wanted to evaluate the effect of an intensive mass-practice 
programme. In the third study we wanted to study the changes in brain activation patterns that 
occur with motor recovery in a selected group of patients with acute ischaemic stroke, treated 
in a stroke unit with early mobilisation and early supported discharge service. The 
background for this work will be presented in the next section.   
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2 Background 
 
2.1 Evidence-based stroke treatment  
 
Evidence-based medicine is the continuous, explicit and careful use of current best evidence 
in making decisions about the care of individual patients. The practice of evidence-based 
medicine means integrating individual clinical expertise with the best available external 
clinical evidence from systematic research (Sackett et al., 2007). The Cochrane Collaboration 
is an international non-profit and independent organisation, dedicated to making up-to-date, 
accurate information about health care readily available worldwide (Cochrane Collaboration, 
2007). In a Cochrane search, 80 reviews with ‘stroke’ in the record title were identified, 
indicating that there might be a considerable amount of evidence about different stroke 
treatments. One of these reviews, ‘Organised inpatient (stroke unit) care for stroke patients’ 
(Stroke Unit Trialists' Collaboration, 2002), provides evidence of the benefit of stroke unit 
treatment. Another review, ‘Services for reducing duration of hospital care for acute stroke 
patients’ (Early Supported Discharge Trialists, 2007), shows growing evidence for early 
supported discharge.
 
2.1.1 Stroke unit treatment 
 
Several randomised controlled trials have been performed in different countries and clinical 
settings to assess the effectiveness of stroke unit care for hospitalised stroke patients. The 
results of these studies show that stroke unit care reduces death and dependency in the short 
and long term (Stroke Unit Trialists' Collaboration, 2002). The complex interventions that 
were used experimentally on small selected groups of patients included in the randomised 
trials are also shown to be applicable and effective for all acute stroke patients admitted to 
stroke units (Candelise et al., 2007; Asplund et al., 2003). 
 
There are different kinds of stroke units, focusing on different aspects of acute stroke 
treatment. They can be most commonly classified as stroke ward, mixed rehabilitation ward 
or mobile stroke team. Stroke wards include: a) acute stroke units, which are an intensive 
model of care with continuous monitoring and high nursing staff levels; b) rehabilitation 
stroke units which accept patients after a delay of around 7 days or more, and which focus on 
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rehabilitation; and c) comprehensive stroke units, a combined acute and rehabilitation ward, 
which accept patients acutely but also provide rehabilitation for several weeks if necessary. A 
mixed rehabilitation ward is likely to be staffed by a multidisciplinary team including 
specialist nurses, in a ward providing a generic rehabilitation service, but not exclusively 
caring for stroke patients. A mobile stroke team is a multidisciplinary team providing care in a 
variety of settings (Stroke Unit Trialists' Collaboration, 2002). The literature indicates that 
stroke units with a strong focus on physical therapy and rehabilitation are the most beneficial 
(Langhorne & Pollock, 2002; Indredavik, 2007).  
 
The Stroke Unit at St. Olavs Hospital is defined as a comprehensive stroke unit. It was 
established in association with a well conducted randomised controlled trial (Indredavik, 
1999), which demonstrated that effective stroke unit treatment increases the proportion of 
patients able to live at home, improves functional outcome, reduces the needs for institutional 
care and reduces early mortality compared to stroke patients treated in a general ward 
(Indredavik et al., 1991). These beneficial effects also persist in the long term (Indredavik et 
al., 1997; Indredavik et al., 1999a). 
 
This stroke unit is now established as one of the normal range of specialist facilities at St. 
Olavs Hospital, and it can be regarded as an evidence-based ward. The important features of 
the care on this ward include diagnostic evaluation and systematic observation during the first 
72 hours, acute medical treatment to reduce the brain damage, early mobilisation, preventing 
complications, initiating secondary prevention, early and regular evaluation of the potential 
for rehabilitation, early initiation of rehabilitation and patient-specific planning for further 
rehabilitation after discharge. Of all these factors, early mobilisation seems to be the most 
important, followed by stabilisation of the diastolic blood pressure (Indredavik et al., 1999b). 
 
2.1.2 Early supported discharge for stroke patients 
 
The provision of acute treatment in a stroke unit is the recommended “gold standard” for all 
patients suffering from acute stroke (Norges forskningsråd, 1995; Aboderin & Venables, 
1996). However, there has been a lack of rigorous evidence about the best treatment after 
discharge from hospital. A clinical trial was designed by  Indredavik and Fjærtoft  with the 
objective of  determining the most effective way of organising post-acute stroke care, so as to 
improve outcomes without increasing the use of health resources (Fjærtoft, 2005). 
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 In this clinical randomised controlled trial, 320 patients were randomly allocated either to a 
standard service, or to an early supported discharge (ESD) service. The results demonstrated 
significantly improved functional outcome and shorter institutional stay for patients in the 
ESD group compared to those in the standard group (Indredavik et al., 2000; Fjaertoft et al., 
2003). A meta-analysis including 11 ESD trials shows an overall reduction in death and 
dependency for patients in the ESD groups. The hospital stay was eight days shorter for 
patients assigned to ESD services compared to those assigned to conventional care. However, 
all the reviewed trials were conducted in urban settings, and the effectiveness and 
appropriateness of ESD service in rural communities should also be tested (Langhorne et al., 
2005; Early Supported Discharge Trialists, 2007).  
 
The successful ESD trial in Trondheim inspired us to replicate the trial for patients living in 
some of the more rural municipalities surrounding the city. Although the patients from this 
area received equivalent treatment within the stroke unit, the hospital was a longer distance 
from their homes, which made it more challenging to interact with both relatives and the 
primary health care service. We wanted to adapt the main points of the ESD service in 
Trondheim and to investigate whether this service was effective and beneficial for patients 
living in the municipalities of Malvik, Melhus and Klæbu. A clinical randomised trial was 
designed to evaluate the effect of an ESD service in a rural setting and the results are 
presented in Paper I and Paper II of this thesis. 
 
2.2 Predicting functional outcome 
 
The quest to identify those factors which can help predict functional recovery after stroke has 
been the subject of extensive research. It has been argued that certain sub-groups of the stroke 
population may benefit more than others from specific rehabilitation services. In order to 
achieve the most efficient use of such services, it is important to identify predictors that 
discriminate between stroke patients with good and poor recovery potential. Several 
prognostic factors such as age, gender, previous stroke, time from onset of stroke to hospital 
admission, severity of paralysis, ischaemic lesion volume, balance and functional admission 
score, have been identified. 
 
 19
Age is assumed to be an important predictor of stroke recovery, with younger patients having 
better outcomes (Jongbloed, 1986; Kwakkel et al., 1996; Jorgensen et al., 1999; Nakayama et 
al., 1994; van de Port et al., 2006). However, age does not influence the neurological aspects, 
suggesting a poorer compensatory ability in elderly stroke patients (Nakayama et al., 1994). 
Outcomes do not seem to differ between men and women (Counsell & Dennis, 2001). The 
influence of previous stroke is somewhat conflicting, showing both no influence (Counsell & 
Dennis, 2001) and an association with poorer outcome (Kwakkel et al., 1996; Woldag et al., 
2006). On the other hand, prolonged time from onset of symptoms to hospitalisation would 
appear to be a valid predictor of recovery of function associated with poorer outcome 
(Kwakkel et al., 1996; van de Port et al., 2006). Initial neurological impairment assessed by 
means of the Scandinavian Stroke Scale score predicts the incidence of death and dependency 
in patients with mild ischaemic stroke (Christensen et al., 2005). The evidence for an 
association between initial leg paresis and functional outcome is also conflicting, showing 
both a strong association between leg paresis and the ability to regain independent walking 
(Wandel et al., 2000; Olsen, 1990; Jorgensen et al., 1995a), and no association between initial 
leg paresis and increased risk of falling when the results were adjusted for depressive 
symptoms (Jorgensen et al., 2002). However, the overall degree of impairment and weakness 
in the acute stage appears to influence functional outcome (Counsell & Dennis, 2001). 
Furthermore, the Barthel Index was the single predictor of walking ability in a multivariate 
model (Wandel et al., 2000). Finally, initial trunk control (Kwakkel et al., 1996; Franchignoni 
et al., 1997; Duarte et al., 2002; Hsieh et al., 2002), and change in standing balance (Kollen et 
al., 2005) are described as significant predictors, influencing the functional outcome after 
stroke. Many of these factors are probably interrelated.   
 
Ischaemic lesion volume is also considered to be an important predictor of post-stroke 
functional outcome, but the role of brain imaging data is not consistent. Magnetic resonance 
diffusion weighted imaging included in a three-item prediction model was validated showing 
good sensitivity and specificity (Baird et al., 2001). However, that particular study may be 
criticised for selection bias, as it included a highly selected group of stroke patients. 
Methodological shortcomings of most studies, such as different neuro-imaging methods, 
different timing of imaging and different outcome assessment, confound the prognostic value 
of magnetic resonance imaging (MRI) in predicting stroke outcome (Schiemanck et al., 2006). 
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The conflicting results in the association between leg paresis and functional outcome might be 
contingent on the different ways of categorising the extent of leg paresis. With reference to 
this issue, we wanted to assess the association between different degrees of initial leg paresis 
as determined by the leg item on the Scandinavian Stroke Scale and balance one year after the 
stroke. Different balance measures also have an impact on assessment of functional outcome. 
The movement item on the Scandinavian Stroke Scale may be used as a simple measure of 
functional balance, and we wanted to assess whether different degrees of initial movement 
ability according to this item were associated with balance one year after the stroke. The 
results of these analyses are presented in Paper II. 
 
2.3 Motor training after stroke 
 
Motor impairments are the most commonly reported impairments after acute stroke, with 
upper limb motor deficits present in 77% and lower limb motor deficits present in 72% of 
patients one week after onset of first-ever stroke (Lawrence et al., 2001). Reduced balance is 
another common motor impairment, and about 50% of those admitted to further rehabilitation 
were not able to stand without support one month after onset of stroke (Benaim et al., 1999). 
However, spasticity would appear to be a less common problem, as it was present in only 
19% of the patients investigated three months after stroke (Sommerfeld et al., 2004).   
 
Motor impairments are associated with reduced self-perceived health (Suenkeler et al., 2002; 
Sturm et al., 2004) and consequently, rehabilitation after stroke has a strong emphasis on 
physiotherapy and motor training. 
 
2.3.1 Different physiotherapy approaches 
 
A range of physiotherapy approaches based on different ideas about motor recovery following 
stroke have been implemented (Pollock et al., 2007). In the 1950s and 1960s neurofacilitation 
approaches based on available neurophysiological knowledge were developed, including the 
Bobath approach (Davies, 1999), which became the most commonly used method. In the 
1980s the potential importance of neurophysiology and motor learning was highlighted 
(Schmidt, 1991) and the motor learning, or relearning, approach (Carr & Shepherd, 1987) was 
proposed. The Bobath approach has emphasised the importance of facilitating movement and 
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of tactile stimulation (hands on) (Davies, 1999), while the Motor Relearning Programme 
emphasises active patient involvement with focus on goal setting, and task-specific practice to 
improve function after stroke (Carr & Shepherd, 1987). Within the Motor Relearning 
Programme approach, the actions to be learned are practiced in an appropriate context, with 
exercises directed specifically at the muscles required for the performance of the action, 
working through the range at which they must generate force. Furthermore, the patients 
practise movement tasks with the therapist as a coach who encourages the performance by 
instruction, manual guidance, demonstration or verbal feedback. Instructions are given in such 
a way as to present a clear goal and to reduce uncertainty. Manual guidance may be used in 
the early phase to give the patient an idea about what to do. The action to be executed can be 
demonstrated either alive or on videotape, and verbal feedback is given to provide 
information about achievement of the goal and how the movement was performed (Carr & 
Shepherd, 1998). Shumway-Coock & Woollacott (2001) describe the Motor Relearning 
Programme as a task-oriented approach based on newer theories of motor control, also 
referred to as a system approach (Woollacott & Shumway-Cook, 1990).  
 
However, anecdotal evidence and the results of questionnaire-based studies suggest that it is 
difficult to distinguish between the practical implementation of the two approaches (van Vliet 
et al., 2001). This is confirmed in the recent review by Pollock et al (2007), who recommends 
that further research should focus on investigating clearly defined and described techniques 
and task-specific interventions regardless of their historical or philosophical origin, in order to 
develop an evidence-based physiotherapy (Pollock et al., 2007). 
 
2.3.2 Task-specific treatment 
 
Dean and Shepherd (Dean & Shepherd, 1997) performed the first randomised placebo-
controlled trial to test the effect of task-specific postural training. They trained chronic stroke 
patients to increase their upper limb radius while seated and to increase the contribution of the 
affected lower leg to support balance. At the end of a two-week programme, subjects were 
able to reach faster and further, to increase the load on the affected foot, and to increase 
activation of affected lower limb leg muscles compared with the control group. This study 
provides strong evidence of the efficacy of task-specific motor training in improving the 
ability to balance during seated reaching activities after stroke (Perennou & Bronstein, 2005).  
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A more recent randomised controlled trial evaluated the effect of a 3-month structured, 
supervised, home-based exercise programme which included task-specific balance training in 
combination with exercises to improve range of motion, strength and endurance. The results 
demonstrated improved recovery in patients treated with the home-based programme 
compared to those treated with usual care (Duncan et al., 2003).   
 
Treadmill training is frequently used to improve endurance in both healthy people and in 
particular patient groups. Treadmill training is also described as a task-specific method to 
improve gait function after stroke. For this purpose two different forms of treadmill training 
exist: body-weight-supported treadmill training (BWSTT) and unsupported treadmill training. 
Wood-Dauphinee & Kwakkel (Wood-Dauphinee & Kwakkel, 2005) have investigated the 
impact of BWSTT that ranges from no support to 40 % support in five randomised controlled 
trials involving 266 stroke patients. The analysis showed significantly better (29 %) gait 
endurance for the BWSTT group, despite great variability in the intensity of the different 
studies. No significant differences according to gait speed, balance or walking ability were 
detected (Wood-Dauphinee & Kwakkel, 2005). In contrast, another meta-analysis showed that 
BWSTT tended to produce a non-significant trend toward higher walking speed compared to 
other interventions, among stroke patients who could walk independently at the start of 
treatment (Moseley et al., 2005). There is no evidence that treadmill training without body-
weight-support has an additional effect on walking compared to conventional gait training 
programmes on the floor (Wood-Dauphinee & Kwakkel, 2005; Moseley et al., 2005).  
 
The benefit of task-specific training to improve muscle strength in the affected arm or leg has 
also been evaluated in some randomised clinical trials (Winstein et al., 2004; Yang et al., 
2006), showing less impairment and greater isometric strength in the affected arm (Winstein 
et al., 2004), increased strength in the affected leg, and improved functional outcome (Yang et 
al., 2006). The intensity of the task-specific intervention varied from 30 minutes progressive 
resistance strength training for the lower extremity per week for four weeks (Yang et al., 
2006), to task-specific functional training of the upper extremity (e.g. pointing or grasping) of 
at least 20 hours within six weeks (Winstein et al., 2004). 
 
Although it would appear that task-specific training is effective in enhancing recovery after 
stroke, there is still no consensus about the appropriate amount or intensity of this training. So 
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it is relevant to ask whether people who receive “more intensive” as opposed to “less 
intensive” rehabilitation in all phases achieve better and faster motor and functional recovery. 
 
2.3.3 More intensive therapy versus less intensive therapy 
 
Intensive training may refer to increased work rate and/or increased amount of training. It 
would appear that the literature in this field most commonly uses the term “intensive training”  
to describe an increased amount of training, and that will be how the term is used in this 
thesis.   
 
Two systematic reviews suggest that early implementation of intensive stroke rehabilitation is 
associated with enhanced and faster improvement of the functional recovery after stroke 
(Kwakkel et al., 1997; Langhorne et al., 1996). A more recent meta-analysis supports the 
hypothesis that augmented exercise therapy has a small but favourable effect on ADL 
(Kwakkel et al., 2004). The intensive rehabilitation group received at least 16 hours more 
exercise therapy within the first six months after stroke than the control group. It should be 
noted that the content of therapy differed between the studies examined, and that this may 
have influenced the results.  
 
Based on this evidence, it would appear that more intensive training is better than less 
intensive training. However, the observation of physical activity between 8 am and 5 pm in 
seven acute stroke units in Melbourne, Australia, revealed that the patients spent only 12,8 % 
of day time walking or in transfer activities (Bernhardt et al., 2004), suggesting a potential for 
increasing the amount of training during the initial hospital stay after acute stroke. However, 
it should also be acknowledged that intensive therapy is not feasible for every patient or 
clinical setting because of the individual’s inability to tolerate the extra therapy sessions 
(Kwakkel et al., 2004).  
 
2.3.4 Constraint-Induced Movement Therapy  
 
Constraint-Induced Movement Therapy (CIMT) is a new and well described therapy which 
combines intensive task-specific training with shaping (i.e. gradual adaptation of the tasks to 
increasingly complex movements as function improves, see section 4.3.2.) and restriction of 
the unaffected limb (Taub et al., 1999a; Sirtori et al., 2003). The theoretical framework of 
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CIMT is based on the learned non-use phenomenon. This phenomenon was revealed through 
the observations of monkeys after experimentally induced upper limb deafferentation, leading 
to reduced use of the affected arm. However, the monkey could be encouraged to use the 
deafferented extremity by restricting movement of the intact limb (Taub & Uswatte, 2003). 
Taub and Uswatte (Taub & Uswatte, 2003) suggest in their synthesis of research on CIMT 
that this non-use is a learning phenomenon. Three possible processes can explain the learned 
non-use: 1) punishment for using the affected limb (e.g. uncoordination and falling or loss of 
food objects), 2) positive reinforcement for using the intact limb and 3) reduced cortical 
representation of the affected limb. Based on this, Taube and Uswatte assume that the 
inability to use the affected limb after stroke may also be explained by the learned non-use 
phenomena, and they propose a family of  techniques which may overcome the learned non-
use (Taub et al., 1999b; Taub & Uswatte, 2003).  
 
CIMT is mainly applied to stroke patients in the subacute or chronic phase, and several 
studies have revealed positive effects of this treatment compared to other treatments in the 
short term (Sterr et al., 2002; Taub et al., 1993; Taub et al., 2006; van der Lee et al., 1999; 
Wittenberg et al., 2003; Wolf et al., 2006). The most recent study by Wolf et al (2006) has 
shown the most convincing effect. In this trial, the short-term effect persisted at one year 
follow-up with significantly better motor function, greater amount of use and better quality of 
movement of the affected arm, as well as better self-perceived hand function. This study is the 
first multisite randomised controlled trial to demonstrate the efficacy of a rehabilitative 
intervention. It therefore moves neuro-rehabilitative care into the area of evidence-based 
medicine (Luft & Hanley, 2006). However, the criteria for inclusion in the CIMT studies cited 
have been strict, and only 6 % of the stroke population fulfilled the criteria for inclusion in the 
EXCITE trial (Wolf et al., 2006). In order to make the intervention more feasible for a greater 
proportion of the stroke population, modified versions of CIMT have also been evaluated 
(Page et al., 2005; Page et al., 2004; Dromerick et al., 2000). Page et al (2005) found that 
individualised, half-hour therapy sessions, three times per week for 10 weeks, combined with 
five hours of restraint on the unaffected arm every weekday, improved arm function 
significantly in a group of acute stroke patients, compared to traditional rehabilitation (Page et 
al., 2005). Modified CIMT may be a feasible and effective treatment for improving function 
and use of the more affected arm in chronic stroke patients as well (Page et al., 2004; 
Dromerick et al., 2000).  
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So far, the majority of CIMT trials have been conducted in the US and only two from Europe 
have been published (Sterr et al., 2002; van der Lee et al., 1999). Given this, we wanted to 
assess the efficacy and feasibility of 6 hours’ daily CIMT organised as group therapy in the 
Norwegian health care system. This trial is reported in Paper III.  
 
2.4 Motor recovery after stroke  
 
In most stroke patients, recovery follows an exponential progression, with a fast initial 
improvement during the first six weeks and a slower recovery for the next six weeks 
(Jorgensen et al., 1995c). Animal studies have shown that the cerebral cortex undergoes 
significant functional plasticity for weeks to months following injury (Nudo & Milliken, 
1996). Spared regions adjacent to the infarction and far removed from the infarction undergo 
functional alterations that are modified by behavioural experience (Nudo, 2007). 
 
It has also been shown in an animal model that rehabilitation initiated five days after focal 
ischaemia was much more effective than waiting for one month before beginning 
rehabilitation (Biernaskie et al., 2004). This study demonstrates significant interaction 
between rehabilitation and spontaneous recovery processes early after stroke. The 
mechanisms of this recovery process may be listed in three general changes within the 
sensorimotor network: restitution, substitution, and compensation (Dobkin & Carmichael, 
2005). Restitution is relatively independent of external variables such as physical and 
cognitive stimulation. Restitution includes reduction of edema, absorption of blood, 
restoration of ionic currents, and restoration of axonal transport (Dobkin & Carmichael, 
2005), and also reperfusion due to vessel recanalisation (Butefisch et al., 2006). Substitution 
depends on external stimuli such as practice with the affected hemiparetic arm or leg during 
rehabilitation. Substitution includes the functional adaptations of diminished, but partially 
restored, neural networks that compensate for components lost or disrupted by the injury. 
Substitution may add a cost to the mental or physical energy needed to carry out a relearned 
motor skill (Dobkin & Carmichael, 2005). This may contribute to explaining some of the 
fatigue experienced by a significant proportion of the stroke population (De Groot et al., 
2003). Compensation aims to improve the mismatch between a patient’s impaired skills and 
the demands of the patient or the environment (Dobkin & Carmichael, 2005).  
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2.4.1 Brain plasticity 
 
A range of imaging techniques have been applied to visualise patterns of altered brain 
activation following stroke, and to characterise changes in activity patterns with recovery and 
rehabilitation. Electroencephalography (EEG) records electrical activity from electrodes at the 
scalp, while magnetoencephalography (MEG) records the magnetic changes associated with 
the changing electrical fields. These approaches offer the advantage of recording signals that 
are closely related to the underlying neuronal activity, and thus have high temporal resolution; 
however, their spatial resolution is limited. In contrast, techniques such as functional magnetic 
resonance imaging (fMRI) or positron emission tomography (PET) record signals related to 
the metabolic or hemodynamic consequences of such electrical activity (Johansen-Berg, 
2007). A methodological challenge is the heterogeneity and absence of blood-oxygen-level-
dependent (BOLD) signals measured in fMRI observed in some studies in patients with 
vascular disease (Binkofski & Seitz, 2004; Krainik et al., 2005; Rossini et al., 2004). Still, 
PET and fMRI offer significant advantages in term of spatial resolution, with fMRI as the  
superior, allowing for fine-grained localisation of the remapping that may occur after stroke 
(Johansen-Berg, 2007). 
  
Several fMRI studies have been undertaken in the past decade to study the role of brain 
plasticity in the recovery after stroke. Both cross-sectional and longitudinal study designs 
have been used, but the longitudinal design would appear to be more appropriate to study the 
evolution of the activity pattern as recovery takes place (Calautti & Baron, 2003). The 
reported patterns of change are variable, but some consistencies have now emerged. These 
may be classified into three major patterns of change: 1) local remapping within the primary 
motor cortex, 2) increased activity in non-primary sensorimotor areas, and 3) increased 
activity in the undamaged hemisphere (Johansen-Berg, 2007). 
 
The local remapping implies a ventral or posterior shift in the location of primary 
sensorimotor (MISI) cortex activation (Pineiro et al., 2001; Calautti et al., 2003; Cramer & 
Crafton, 2006). There are recent suggestions that smaller infarction volumes are associated 
with more ventral and larger infarction volumes with more posterior activation foci. On the 
other hand, better behavioural outcome would appear to be associated with greater posterior 
activation, and poorer outcome with a more ventral activity (Cramer & Crafton, 2006). 
Increased recruitment of non-primary motor areas, such as inferior parietal cortex, cingulate 
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cortex and pre-motor cortex has been reported (Tombari et al., 2004; Nelles et al., 1999; 
Loubinoux et al., 2003). It is suggested that this pattern represents adaptive plasticity, in 
which undamaged areas of cortex take over the function of the damaged regions. It is 
proposed that this pattern will never result in complete recovery (Calautti & Baron, 2003; 
Johansen-Berg, 2007). A number of studies have reported increased activity of the unaffected 
sensorimotor cortex following stroke (Cao et al., 1998; Cramer et al., 1997; Gerloff et al., 
2006; Thiel et al., 2007; Schaechter & Perdue, 2008), suggesting a significant role for the 
non-stroke hemisphere in mediating recovery. Although the majority of corticospinal outputs 
are crossed, approximately 30% of them remain uncrossed. It is suggested that these fibres 
bring signals from the undamaged hemisphere to the affected side of the body (Iwamura et al., 
2001).  
 
2.4.2 Motor learning and recovery  
 
Motor learning is defined as a set of processes associated with practice that lead to relatively 
permanent change in performance capability (Schmidt, 1991). Studies in healthy humans have 
demonstrated that incremental acquisition of motor skills follows two distinct stages: first, an 
early, fast learning stage in which considerable improvement in performance can be seen 
within a single training session, and secondly, a later, slow stage in which further gains can be 
observed across several sessions (and even weeks) of practice (Doyon et al., 2003). It is 
proposed in an animal model that motor skill acquisition, or motor learning, is a prerequisite 
for task-related changes in the activation maps of primary motor cortex (Plautz et al., 2000), 
and consequently it is suggested that motor learning is required for both substitution, i.e. when 
undamaged brain regions are recruited to generate commands to the same muscles as were 
used before the injury (true recovery), and compensation, i.e. the use of alternative muscles to 
accomplish the task goal (Krakauer, 2006). Several brain structures, including the striatum, 
cerebellum, and motor cortical regions of the prefrontal lobe, are considered to be critical for 
acquisition of motor skilled behaviour, and it is suggested that the acquisition of motor skills 
reproduces changes in the cortico-striatal and cortico-cerebellar systems over the course of 
motor skill learning in healthy subjects (Doyon et al., 2003).  
 
Previous longitudinal brain imaging studies after stroke have mainly focused on the neural 
correlates to motor recovery, but not on whether these changes share features with brain 
plasticity in healthy subjects over the course of motor skill learning. The task-oriented 
 28 
approaches, particularly the Motor Relearning Programme, are based on motor learning 
principles assuming that recovery after stroke i.e. relearning of lost motor skills, are 
comparable to motor learning in healthy subjects (Carr et al., 1987). Whether brain activation 
corresponding to motor recovery following stroke can be explained by motor learning 
mechanisms is still undetermined. In the last paper of this thesis, we wanted to study the 
motor network changes in patients admitted to a comprehensive stroke unit, treated with early 
mobilisation and physiotherapy according to a task-oriented approach, within the framework 
of motor learning.  
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3 Aims of the thesis 
 
The overall aim of this thesis was to increase the knowledge about recovery, particularly 
motor recovery, after stroke, by evaluating the effect of one multidisciplinary rehabilitation 
programme and one intensive mass-practice programme compared to standard treatment 
programmes, and to investigate changes in brain activation over the course of motor recovery 
after stroke.  
 
The specific aims are: 
 
• To evaluate the effect of an ESD service coordinated by a multidisciplinary mobile 
stroke team for patient with acute stroke living in a rural community (Paper I and 
Paper II). 
 
• To assess the association between initial leg paresis and initial movement ability and 
balance one year after stroke (Paper II). 
 
• To evaluate the effect and feasibility of Constraint-Induced Movement Therapy for 
patients with subacute and chronic stroke admitted to an in-patient rehabilitation clinic 
(Paper III). 
 
• To assess the early motor network changes in a group of stroke patients treated in a 
comprehensive stroke unit, and to investigate its relationship to motor learning (Paper 
IV). 
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4 Material and Methods 
 
This thesis includes two randomised controlled trials: one early supported discharge trial 
(ESD trial) and one constraint-induced movement therapy trial (CIMT trial), as well as a 
longitudinal functional MRI study (fMRI study). They are presented in four papers (Paper I-
IV). An integrated stroke service provided as a framework for this project (Figure 1).  
 
 
 
Figure 1. A model for the studies implemented in this thesis (The illustration is adapted 
with permission from the Early Supported Discharge Trialists) 
 
4.1 Study participants 
 
Three different samples, including acute, subacute and chronic stroke patients, were studied. 
Patients admitted to the stroke unit at St. Olavs Hospital were screened for inclusion in the 
ESD trial and the fMRI study, while patients within the area of the Central Norway Regional 
Health Authority were screened for inclusion in the CIMT trial. The inclusion criteria are 
described in Table 1, and the baseline characteristics of the included patients are listed in 
Table 2. 
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 Table 1. Inclusion criteria for patients screened for inclusion into Paper I-IV 
Study population N Eligibility criteria Paper 
 
Patients with the 
diagnosis of acute 
stroke, admitted to the 
Stroke Unit at St. Olavs 
Hospital, living in the 
municipality of Malvik, 
Melhus or Klæbu  
62 1) Scandinavian Stroke Scale (SSS) score greater 
than 2 points and less than 58 points. 
2) Living at home before the stroke. 
3) Inclusion within 72 hours after admission to 
the stroke unit and seven days after onset of 
symptoms. 
4) Able and willing to provide informed consent 
 
I, II 
 
 
Patients with the 
diagnosis of subacute 
and chronic stroke 
living within the area of 
Central Norway 
Regional Health 
Authority 
30 1) Age: 18 - 80 years 
2) More than two weeks from onset of stroke 
3) Weakness or reduced dexterity of the affected 
hand 
4) More than 20˚ active wrist extension and 10˚ 
active finger extension 
5) More than 20 points on Mini Mental State 
Examination (MMSE) 
6) Less than 13 points on Montgomery and 
Aasberg Depression Rating Scale 
7) Less than 2 cm deviation from the midline on 
line bisection 
8) No other neurological diseases 
9) More than 6 months’ life expectancy 
10) Sufficient endurance to participate, evaluated 
by clinical assessment 
11) Able and willing to provide informed consent 
 
III 
Patients with the 
diagnosis of acute 
stroke, admitted to the 
Stroke Unit at St. Olavs 
Hospital, living in the 
municipality of 
Trondheim, Malvik, 
Melhus or Klæbu 
12 1) First-ever stroke 
2) Age: 50 - 75 years  
3) No other diseases in the central nervous 
system 
4) Modified Rankin Scale score less than 3 points 
before the stroke 
5) Hand item or arm item on SSS more than 0 
points and less than 6 points 
6) Six points on the consciousness item on SSS   
7) Inclusion 4 to 7 days after onset of symptoms 
8) More than 20 points on MMSE 
9) Can tolerate MRI scanning  
10) No contraindication to MRI scanning 
11) Able and willing to provide informed consent 
 
IV 
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Table 2. Baseline characteristics for patients included in Paper I-IV 
Study ESD trial CIMT trial fMRI study 
Paper Paper I, II Paper III Paper IV 
Design Randomised 
controlled trial 
Randomised 
controlled trial 
Longitudinal 
follow-up 
Group allocation TG CG TG CG  
N 31 31 18 12 12 
Age (years), mean (SD) 77 (  7) 76 (  9) 62 (  8) 60 (12) 67 (  5)
Gender, number (%) male 16 (52) 17 (55) 16 (89) 7 (58) 8 (67)
  
Medical history, number (%)  
Transient ischaemic attack 6 (19) 2 (  7) 0 (  0) 2 (17) 1 (  1)
Stroke 2 (  7) 1 (  3) 1 (  6) 2 (17) 0 (  0)
Myocardial infarction 5 (16) 7 (23) 3 (17) 2 (17) 1 (  1)
Atrial fibrillation 3 (10) 8 (26) 2 (11) 0 (  0) 1 (  1)
Hypertension 3 (10) 10 (32) 8 (44) 5 (42) 4 (33)
Diabetes 1 (  3) 5 (16) 4 (22) 3 (25) 2 (17)
TG, treatment group; CG, control group 
 
 
4.2 Study intervention applied in the ESD trial (Paper I and II) 
 
4.2.1 The standard stroke unit service 
 
The patients in the standard service group were offered the well documented treatment for 
stroke patients in the Stroke Unit at St. Olavs Hospital (Indredavik et al., 1991; Indredavik et 
al., 1997; Indredavik et al., 1998; Indredavik et al., 1999a). This treatment is defined as the 
stroke unit treatment of choice according to evidence-based recommendations. After 
discharge from the hospital, further rehabilitation was delivered by the primary health care 
system in the municipalities of Malvik, Melhus and Klæbu. However, the primary health care 
system was organised differently in each of these three municipalities. Melhus was the only 
municipality with a community-based in-patient rehabilitation clinic. In addition, the number 
of occupational and physical therapists varied widely. Traditionally, patients were discharged 
to further in-patient rehabilitation in a nursing home or back to their homes.  
 
The standard stroke unit service is described as an ordinary stroke unit service (OSUS) in 
Paper I and Paper II. 
 
 
 33
4.2.2 The early supported discharge service 
 
The early supported discharge (ESD) service was developed during a previous trial for 
patients living in the city of Trondheim (Indredavik et al., 2000; Fjaertoft et al., 2003; 
Fjaertoft et al., 2004). It comprised the standard stroke unit service combined with a home-
based programme of follow-up care coordinated by a multidisciplinary hospital outreach 
stroke team which offers early supported discharge. 
 
The multidisciplinary team was based within the stroke unit and comprised a nurse, a 
physiotherapist, an occupational therapist and the consultant availability of a physician. The 
team was specially trained to organise and coordinate the follow-up in cooperation with the 
primary health care system and to offer support during the first four weeks after discharge 
from the stroke unit. An important feature of this cooperation was the transfer of expertise 
about the diagnosis of stroke and stroke treatment to the primary health care system. In 
principle, the same primary healthcare system was available to patients in both groups, but the 
multidisciplinary team was only available to the ESD group.  
 
The locality covered by the three participant municipalities may be described as a rural 
community with a dispersed settlement pattern, indicating that the patient’s home is likely to 
be a long distance away from the community centre and the hospital. As soon as a patient was 
randomised to the ESD service, the team was contacted, and one of the three team members 
started collecting information about the patient’s previous and present functioning, disabilities 
and contextual factors. At the same time the primary healthcare system was informed about 
the patient. For those patients living within 45 minutes driving distance from the hospital, 
where direct discharge to home was likely to occur, a home visit was usually made as soon as 
the medical condition of the patient allowed this. The aim of the visit was to assess the home 
environment, to define the goals of further rehabilitation and to make a plan for follow-up 
together with the family and the primary healthcare providers. For those patients living more 
than 45 minutes from the hospital, we asked the primary healthcare providers to make this 
visit. The need for further rehabilitation was subsequently defined over the telephone. The 
team member then established a service and support system for the patient, allowing them to 
return home as soon as possible and to continue the necessary training and rehabilitation at 
home, in a day clinic or both. On the day of discharge, a meeting was organised with the 
patient and his/her family, the physician and the mobile stroke team member. The aim of the 
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meeting was to jointly define the plans for further follow-up care. The definite day of 
discharge was decided in collaboration with the team member, the patient and their family. 
 
For patients with extensive deficits after a stroke who needed help and support 24 hours a day, 
plans for further in-patient follow-up in a rehabilitation clinic were made.  
 
During the first four weeks after discharge the multidisciplinary team acted as a safety net for 
the patient, and kept in contact both by telephone and by at least one other home visit to 
ensure the appropriate level of follow-up care. This period of close follow-up by the mobile 
team terminated with an outpatient consultation for those patients living within 45 minutes 
driving distance from the hospital. A consultation was conducted in the patient’s home for 
patients living farther from the hospital. The physician responsible for the patient’s treatment 
during the acute hospital stay, the team member, the patient, and if possible, the family 
participated in this visit.  
 
When a group of patients was identified within the same community, the patients and their 
families were invited to a local meeting. The aim of this meeting was to give general 
information about acute and chronic issues of stroke care, as well as to give the patients an 
opportunity to share their experiences.  
 
The ESD service is described as an extended stroke unit service with early supported 
discharge (ESUS) in Paper I and Paper II. 
 
4.3 Study intervention applied in the CIMT trial (Paper III) 
 
4.3.1 Standard rehabilitation 
 
The patients in the control group received standard rehabilitation which was defined as 
community-based follow-up treatment according to each patient’s needs, involving both upper 
and lower extremity training. When long-term rehabilitation was necessary, in-patient 
rehabilitation was given, including both physiotherapy and occupational therapy. Patients 
were otherwise, or after in-patient rehabilitation, followed up by the primary health care 
system, including physiotherapy mainly provided over two sessions per week.  
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The standard rehabilitation is described as traditional rehabilitation in Paper III.  
 
4.3.2 Constraint-Induced Movement Therapy  
 
The patients in the intervention group received Constraint-Induced Movement Therapy 
(CIMT) at a level close to that described by Taub et al (Taub et al., 2006). Although the 
original CIMT is described as a one-to-one therapy, we wanted to organise it as group 
therapy, with up to four patients in each group, led by a physiotherapist, with an occupational 
therapist, and assisted by a nurse when needed. The three key principles of CIMT are 
described below: 
 
1) Forced use of the affected arm 
The patients were expected to restrain the unaffected arm by wearing a mitten during most of 
their waking hours. The occupational therapist designed and made a mitten with no fingers 
and a firm plastic material at the volar side. To make the mitten more comfortable the dorsal 
side was made of light material (Figure 2). The mitten was one size, and fitted both the right 
and the left hand. It could easily be removed during activities dealing with water, warm 
drinks, at the toilet, and for safety reasons such as walking with a cane. The removal of the 
mitten was registered in a log.  
 
2) Shaping movements 
The next principle is training through the use of shaping movements of the affected arm. 
Shaping implies gradual adaptation of the tasks to increasingly complex movements as 
function improves, and is described in detail in the supplementary Appendix I, available 
online at http://stroke.ahajournals.org (Taub et al., 2006). Every patient formulated five goals 
related to ADL or to leisure activities, before the training started. After assessing the motor 
function and functional ability, the therapists designed an individual activity plan adjusted to 
the patients’ abilities and goals. Significant tasks were chosen from a collection of about 150 
functional tasks within ten domains. The domains were: personal care, kitchen and household, 
games, handicrafts, gardening, office work, shopping, sports, strength and mobility. 
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 Figure 2. The mitten on the less affected hand 
 
The tasks included both functional tasks such as laying the table, and more specific training in 
the components of the functional tasks. The activities ranged from simple to complex tasks 
and were individually adjusted with regard to number of repetitions, tempo, resistance, range 
of motion, and weight.  
 
3) Mass practice 
The third principle was massing the practice of both shaping movements 6 hours per day and 
restraining the unaffected arm during 90% of waking hours. A schedule for a two-week period 
was prepared, and every day started with preparing and eating breakfast at eight o’clock. This 
was followed by exercises of the affected hand within the different domains until the 
afternoon. The participants had short breaks when they moved from one domain of activity to 
another after approximately half an hour. The therapists encouraged and motivated the 
patients to maintain a high intensity of activity during the exercises, and the nursing staff 
encouraged and motivated the patients to keep the mitten on during the rest of the waking 
hours. 
 
4.4 Study intervention applied in the fMRI study (Paper IV) 
 
The fMRI study had no specific study intervention, but all patients were treated in a 
comprehensive stroke unit at St. Olavs Hospital (Indredavik et al., 1991) with emphasis on 
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mobilisation within the first 24 hours after onset of symptoms and physiotherapy according to 
a task-oriented approach (Indredavik et al., 1999b). Further follow-up care was coordinated 
by a multidisciplinary team for the first four weeks after discharge (Indredavik et al., 2000; 
Askim et al., 2004). Hence, all patients received the recommended “gold standard” of stroke 
treatment. 
 
4.5 Outcome measures (Paper I-IV) 
 
A battery of appropriate generic and specific outcome measures is used in this thesis. Generic 
measurements are developed for use in a general, apparently healthy, population and may be 
used to compare the level of disability within different groups of patients (e.g., Barthel Index, 
walking speed). The specific measures are designed for a population with a specific disease, 
with items specific to the problems of the client population (e.g. Stroke Impact Scale, Motor 
Assessment Scale). Generic measures tend to be less sensitive to change compared to the 
specific measures (Finch et al., 2002). 
 
4.5.1 A conceptual framework 
 
Several measurement paradigms are helpful in organising outcomes with respect to the 
various health effects experienced by clients and the short- and long-term effects of therapy. 
The World Health Organisation’s (WHO) International Classification of Functioning, 
Disability and Health (ICF) is one of the most relevant to the evaluation of physical 
rehabilitation (Finch et al., 2002). 
 
ICF is a multipurpose classification designed to provide a scientific basis for understanding 
and studying health and health-related states, outcomes and determinants, and to establish a 
common language for describing health and health-related states in order to improve 
communication between different users (World Health Organization, 2001). ICF has two 
parts: (1) functioning and disability, and (2) contextual factors. Functioning and disability 
consist of the components: (a) body functions and structures, and (b) activities and 
participation. Contextual factors consist of the components: (c) environmental factors, and (d) 
personal factors (World Health Organization, 2001). In order to visualise the current 
understanding of the interaction of various components, a model of Functioning and 
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Disability is presented in Figure 3 (World Health Organization, 2001). 
 
 
Figure 3. Interaction between the components of ICF 
(http://www.who.int/classifications/icf/site/intros/ICF-Eng-Intro.pdf) 
 
Outcomes may be measured at any of these levels: 
1. Body Function and Structure (impairment): problems in body function or structure as 
a significant deviation or loss. 
2. Activities: the execution of a task or action by an individual. 
3. Participation: the involvement in a life situation. 
 
Body Function and Structure and Activities and Participation are all affected by 
environmental and personal factors (referred to as contextual factors within the ICF).  
 
The outcomes measured in this thesis are listed in Table 3 in terms of the above-mentioned 
levels.  
 
4.5.2 Reliability and validity 
 
Several aspects of reliability and validity should be considered when choosing an appropriate 
measurement. Internal consistency, test-retest reliability and inter-rater reliability are three 
types of reliability. Internal consistency is applicable when multi-item measures are 
 39
 40 
summarised into a single score (Finch et al., 2002). Test-retest reliability, based on parallel 
assessments of clients on different occasions and inter-rater reliability, based on parallel 
assessments by different raters, will be considered for the measures reported in Table 3.  
 
Face validity, content validity, criterion validity and construct validity are considered when 
the degree of validity of a measurement is evaluated. Face validity considers whether a 
measure appears to measure what it is intended to measure. Content validity exists to the 
extent that a measure is composed of a comprehensive sample of items that completely assess 
the domain of interest. Criterion validity examines the extent to which a measure provides 
results that are consistent with a gold standard. Typically, criterion validity is divided into 
concurrent validity and predictive validity. In the absence of a gold standard, the construct 
validity has to be considered. Construct validity involves forming theories about the attribute 
of interest and then assessing the extent to which the measure under investigation provides 
results that are consistent with the theories (Finch et al., 2002). Available and appropriate 
aspects of validity will be reported for the measurements used in this thesis in Table 3. 
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II
I 
Th
e 
M
od
ifi
ed
 
R
an
ki
n 
Sc
al
e 
(m
R
S)
 
To
 a
ss
es
s t
he
 
ov
er
al
l 
in
de
pe
nd
en
ce
 
in
 st
ro
ke
 
pa
tie
nt
s. 
D
eg
re
e 
of
 
in
de
pe
nd
en
ce
 
ra
te
d 
on
 a
 0
 –
 6
 
sc
al
e.
 T
he
 
di
ch
ot
om
is
ed
 
sc
al
e 
w
ith
 
m
R
S≤
2 
de
fin
ed
 
as
 fa
vo
ur
ab
le
 
ou
tc
om
e 
is
 
us
ed
 in
 P
ap
er
 I.
 
Te
st
-r
et
es
t r
el
ia
bi
lit
y:
  
κ w
=0
.9
5 
w
ith
 tw
o 
w
ee
ks
 in
te
rv
al
 fo
r 
su
bj
ec
ts
 w
ith
 st
ro
ke
 o
f v
ar
yi
ng
 se
ve
rit
y 
(W
ol
fe
 e
t a
l.,
 1
99
1)
 
 In
te
r-
ra
te
r r
el
ia
bi
lit
y:
  
κ w
=0
.9
0 
be
tw
ee
n 
di
ff
er
en
t r
at
er
s r
at
in
g 
su
bj
ec
ts
 w
ith
 st
ro
ke
 o
f v
ar
yi
ng
 se
ve
rit
y 
(v
an
 S
w
ie
te
n 
et
 a
l.,
 1
98
8)
. 
  
C
on
st
ru
ct
 v
al
id
ity
:  
Th
er
e 
is
 a
 re
la
tio
ns
hi
p 
be
tw
ee
n 
m
R
S 
an
d 
B
ar
th
el
 In
de
x 
at
 d
iff
er
en
t s
ta
ge
s 
af
te
r s
tro
ke
 (B
an
ks
 &
 M
ar
ot
ta
, 2
00
7)
. 
Th
er
e 
ar
e 
ev
id
en
ce
 fo
r t
he
 a
ss
oc
ia
tio
n 
be
tw
ee
n 
m
R
S 
an
d 
ty
pe
 o
f i
sc
ha
em
ic
 
st
ro
ke
 a
nd
 a
cu
te
 n
eu
ro
lo
gi
ca
l 
im
pa
irm
en
t (
B
an
ks
 &
 M
ar
ot
ta
, 2
00
7)
. 
N
ot
 se
ns
iti
ve
 to
 sm
al
l c
ha
ng
es
, 
es
pe
ci
al
ly
 th
e 
di
ch
ot
om
is
ed
 sc
al
e 
(W
ad
e,
 1
99
2)
  
I, 
II
, 
IV
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T
es
t 
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ra
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et
er
s 
 R
el
ia
bi
lit
y 
 
 V
al
id
ity
 e
st
im
at
es
 
 Pa
pe
r 
B
al
an
ce
 
B
er
g 
B
al
an
ce
 
Sc
al
e 
(B
B
S)
 
To
 a
ss
es
s 
ba
la
nc
e 
in
 
ev
er
yd
ay
 
m
ot
or
 
ac
tiv
iti
es
. 
Su
m
m
ar
y 
sc
or
e 
(0
-5
6)
 o
f 1
4 
m
ot
or
 ta
sk
s, 
ra
te
d 
on
 a
 0
-4
 
sc
al
e 
Te
st
-r
et
es
t r
el
ia
bi
lit
y:
  
IC
C
=0
.9
9 
in
 a
 g
ro
up
 o
f c
hr
on
ic
 st
ro
ke
 
pa
tie
nt
s (
B
er
g 
et
 a
l.,
 1
99
5)
. 
 In
te
r-
ra
te
r r
el
ia
bi
lit
y:
  
IC
C
=0
.9
9 
in
 a
 g
ro
up
 o
f e
ld
er
ly
 p
eo
pl
e 
w
ith
 im
pa
ire
d 
ba
la
nc
e 
(B
er
g 
et
 a
l.,
 
19
92
). 
 
IC
C
=0
.9
8 
in
 a
 g
ro
up
 o
f c
hr
on
ic
 st
ro
ke
 
pa
tie
nt
s (
B
er
g 
et
 a
l.,
 1
99
5)
. 
  
C
on
te
nt
 v
al
id
ity
:  
C
on
te
nt
 w
as
 d
ev
el
op
ed
 in
 th
re
e 
ph
as
es
, 
ea
ch
 in
cl
ud
in
g 
a 
di
ff
er
en
t p
an
el
 o
f 
cl
ie
nt
s a
nd
 p
ro
fe
ss
io
na
l (
B
er
g 
et
 a
l.,
 
19
89
). 
C
rit
er
io
n 
va
lid
ity
: 
A
 sc
or
e 
le
ss
 th
an
 4
5 
in
di
ca
te
s t
ha
t a
n 
in
di
vi
du
al
 m
ay
 b
e 
at
 g
re
at
er
 ri
sk
 o
f 
fa
lli
ng
 (B
er
g 
et
 a
l.,
 1
99
2)
.  
53
%
 se
ns
iti
vi
ty
 to
 d
et
ec
t f
al
le
rs
 a
m
on
g 
el
de
rly
 p
eo
pl
e 
(B
og
le
 T
ho
rb
ah
n 
&
 
N
ew
to
n,
 1
99
6)
. 
Su
bj
ec
ts
 w
ith
 B
B
S 
sc
or
e 
of
 3
6 
an
d 
be
lo
w
 a
re
 a
t e
xt
re
m
el
y 
hi
gh
 ri
sk
 o
f 
fa
lli
ng
 (S
hu
m
w
ay
-C
oo
k 
et
 a
l.,
 1
99
7)
 
C
on
st
ru
ct
 v
al
id
ity
:  
H
ig
h 
co
rr
el
at
io
n 
be
tw
ee
n 
B
B
S 
an
d 
B
I 
m
ob
ili
ty
 su
bs
ca
le
 a
nd
 b
et
w
ee
n 
B
B
S 
an
d 
Fu
gl
-M
ey
er
, b
al
an
ce
 su
bs
ca
le
 d
ur
in
g 
th
e 
fir
st
 tw
el
ve
 w
ee
ks
 a
fte
r s
tro
ke
 (B
er
g 
et
 
al
., 
19
92
). 
D
is
cr
im
in
at
es
 a
m
on
g 
pe
rs
on
s u
si
ng
 
di
ff
er
en
t k
in
ds
 o
f w
al
ki
ng
 a
id
s (
B
er
g 
et
 
al
., 
19
92
). 
II
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 R
el
ia
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lit
y 
 
 V
al
id
ity
 e
st
im
at
es
 
 Pa
pe
r 
M
ob
ili
ty
 a
nd
 m
ot
or
 fu
nc
tio
n 
 
 
 
 
W
al
ki
ng
 sp
ee
d 
To
 a
ss
es
s 
as
pe
ct
 o
f 
no
rm
al
 a
nd
 
pa
th
ol
og
ic
al
 
ga
it.
 
Ti
m
e 
to
 w
al
k 
5 
m
et
re
s a
t 
m
ax
im
um
 p
ac
e 
(m
/s
) 
Te
st
-r
et
es
t r
el
ia
bi
lit
y:
 
r=
0.
91
 fo
r m
ax
im
um
 sp
ee
d 
in
 a
 g
ro
up
 o
f 
he
al
th
y 
vo
lu
nt
ee
rs
 (B
oh
an
no
n,
 1
99
7)
. 
r=
0.
93
 a
nd
 IC
C
 (2
.1
)=
0.
92
 fo
r 
co
m
fo
rta
bl
e 
w
al
ki
ng
 sp
ee
d 
w
ith
 o
ne
-d
ay
 
in
te
rv
al
 in
 a
 st
ro
ke
 p
op
ul
at
io
n 
(E
va
ns
 e
t 
al
., 
19
97
). 
In
te
r-
ra
te
r r
el
ia
bi
lit
y:
 
IC
C
=0
.9
98
 fo
r f
as
t w
al
ki
ng
 sp
ee
d 
in
 
pe
rs
on
s w
ith
 tr
au
m
at
ic
 b
ra
in
 in
ju
ry
 (v
an
 
Lo
o 
et
 a
l.,
 2
00
3)
 
C
rit
er
io
n 
va
lid
ity
: 
G
ai
t s
pe
ed
 h
as
 b
ee
n 
us
ed
 a
s t
he
 g
ol
d 
st
an
da
rd
 to
 v
al
id
at
e 
nu
m
er
ou
s o
ut
co
m
e 
m
ea
su
re
s i
n 
di
ff
er
en
t p
at
ie
nt
 p
op
ul
at
io
ns
 
(F
in
ch
 e
t a
l.,
 2
00
2)
. 
C
on
st
ru
ct
 v
al
id
ity
: 
M
ax
im
um
 w
al
ki
ng
 sp
ee
d 
co
rr
el
at
es
 w
ith
 
m
us
cl
e 
st
re
ng
th
 in
 th
e 
lo
w
er
 e
xt
re
m
ity
 
(B
oh
an
no
n,
 1
99
7)
. 
II
 
D
yn
am
om
et
er
 
(J
am
ar
) 
To
 a
ss
es
s 
tra
ns
ve
rs
al
 
gr
ip
 st
re
ng
th
 
Th
e 
m
ea
n 
of
 
th
re
e 
tri
al
s o
f 
m
ax
im
al
 fo
rc
e 
(k
g/
lb
). 
Te
st
-r
et
es
t r
el
ia
bi
lit
y:
 
IC
C
 (2
.1
) =
0.
85
 in
 a
 g
ro
up
 o
f 
as
ym
pt
om
at
ic
 p
er
so
ns
 (C
ol
dh
am
 e
t a
l.,
 
20
06
). 
IC
C
=0
.9
1 
ov
er
 th
re
e 
se
ss
io
ns
 
w
ith
 o
ne
 w
ee
k 
in
te
rv
al
 in
 a
 g
ro
up
 o
f 
ch
ro
ni
c 
st
ro
ke
 p
at
ie
nt
s (
af
fe
ct
ed
 h
an
d)
 
(B
oi
ss
y 
et
 a
l.,
 1
99
9)
. 
In
te
r-
ra
te
r r
el
ia
bi
lit
y:
  
IC
C
=0
.9
6 
in
 a
 g
ro
up
 o
f p
at
ie
nt
s w
ith
 
tra
um
a 
di
so
rd
er
s (
M
ac
D
er
m
id
 e
t a
l.,
 
19
94
). 
C
rit
er
io
n 
va
lid
ity
: 
Fa
ilu
re
 to
 re
co
ve
r m
ea
su
ra
bl
e 
gr
ip
 
st
re
ng
th
 b
ef
or
e 
24
 d
ay
s w
as
 a
ss
oc
ia
te
d 
w
ith
 a
bs
en
ce
 o
f u
se
fu
l a
rm
 fu
nc
tio
n 
at
 
th
re
e 
m
on
th
s (
H
el
le
r e
t a
l.,
 1
98
7)
. 
C
on
st
ru
ct
 v
al
id
ity
:  
Im
pr
ov
em
en
t i
n 
gr
ip
 st
re
ng
th
 is
 
as
so
ci
at
ed
 w
ith
 re
co
ve
ry
 o
f m
or
e 
co
m
pl
ex
 ta
sk
s i
n 
st
ro
ke
 p
at
ie
nt
s 
(S
un
de
rla
nd
 e
t a
l.,
 1
98
9)
.  
IV
 
Pi
nc
hm
et
er
 
(J
am
ar
) 
To
 a
ss
es
s 
ke
y 
gr
ip
 
st
re
ng
th
  
Th
e 
m
ea
n 
of
 
th
re
e 
tri
al
s o
f 
m
ax
im
al
 fo
rc
e 
(k
g)
. 
Te
st
-r
et
es
t r
el
ia
bi
lit
y:
 
N
ot
 a
ss
es
se
d 
In
te
r-
ra
te
r r
el
ia
bi
lit
y:
 
IC
C
=0
.9
7 
in
 a
 g
ro
up
 o
f p
at
ie
nt
s w
ith
 
tra
um
a 
di
so
rd
er
s (
M
ac
D
er
m
id
 e
t a
l.,
 
19
94
). 
N
ot
 a
va
ila
bl
e 
IV
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pa
ra
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et
er
s 
 R
el
ia
bi
lit
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 V
al
id
ity
 e
st
im
at
es
 
 Pa
pe
r 
U
pp
er
 li
m
b 
M
ot
or
 
A
ss
es
sm
en
t 
Sc
al
e 
su
bs
ca
le
 
(U
L-
M
A
S)
 
To
 a
ss
es
s 
th
e 
m
ot
or
 
fu
nc
tio
n 
of
 
th
e 
up
pe
r 
ex
tre
m
ity
 
af
te
r s
tro
ke
 
Su
m
m
ar
y 
sc
or
e 
(0
-1
8)
 o
f t
he
 
up
pe
r l
im
b 
ite
m
s (
ite
m
 6
, 7
 
an
d 
8)
 o
f t
he
 
to
ta
l M
ot
or
 
A
ss
es
sm
en
t 
Sc
al
e 
(M
A
S)
 
(C
ar
r e
t a
l.,
 
19
85
). 
 
 Ea
ch
 it
em
 is
 
ra
te
d 
on
 a
 0
-6
 
sc
al
e.
 
Te
st
-r
et
es
t r
el
ia
bi
lit
y:
 
r=
0.
98
 in
 M
A
S 
(C
ar
r e
t a
l.,
 1
98
5)
. 
 In
te
r-
ra
te
r r
el
ia
bi
lit
y:
 
r=
0.
98
 –
 1
.0
0 
fo
r t
he
 u
pp
er
 li
m
b 
ite
m
s 
(P
oo
le
 &
 W
hi
tn
ey
, 1
98
8)
.  
IC
C
 (2
.1
)=
0.
93
 –
 1
.0
0 
fo
r i
te
m
 6
, 7
, a
nd
 
8 
on
 th
e 
N
or
w
eg
ia
n 
ve
rs
io
n 
of
 M
A
S 
(K
je
nd
ah
l e
t a
l.,
 2
00
5)
. 
  
C
on
te
nt
 v
al
id
ity
: 
Th
e 
ite
m
s a
nd
 sc
or
in
g 
op
tio
ns
 a
re
 b
as
ed
 
on
 th
e 
ob
se
rv
at
io
n 
an
d 
pr
og
re
ss
 o
f a
 
la
rg
e 
nu
m
be
r o
f s
tro
ke
 p
at
ie
nt
s (
C
ar
r e
t 
al
., 
19
85
). 
C
on
st
ru
ct
 v
al
id
ity
:  
A
ll 
th
re
e 
ite
m
s a
re
 m
ea
su
rin
g 
th
e 
sa
m
e 
co
ns
tru
ct
 a
nd
 th
e 
su
m
 sc
or
e 
of
 th
e 
U
L-
M
A
S 
ca
n 
be
 in
te
rp
re
te
d 
as
 a
 to
ta
l s
co
re
 
fo
r u
pp
er
 li
m
b 
fu
nc
tio
n 
(L
an
ni
n,
 2
00
4)
. 
Ite
m
 6
,7
 a
nd
 8
 o
n 
M
A
S 
co
rr
el
at
es
 v
er
y 
w
el
l w
ith
 F
ug
l-M
ey
er
 A
ss
es
sm
en
t u
pp
er
 
ex
tre
m
ity
 p
or
tio
n 
(r
=0
.9
3)
 (M
al
ou
in
 e
t 
al
., 
19
94
). 
IV
 
N
in
e 
H
ol
e 
Pe
g 
Te
st
 (N
H
PT
) 
To
 a
ss
es
s 
m
an
ua
l 
de
xt
er
ity
 
Ti
m
e 
to
 p
la
ce
 9
 
pe
gs
 w
ith
in
 1
20
 
se
co
nd
s (
s)
. T
he
 
m
ea
n 
of
 tw
o 
tri
al
s i
s u
se
d 
as
 
a 
te
st
 p
ar
am
et
er
. 
 
Te
st
-r
et
es
t r
el
ia
bi
lit
y:
  
r=
0.
45
9 
fo
r t
he
 ri
gh
t h
an
d 
an
d 
r=
0.
44
2 
fo
r t
he
 le
ft 
ha
nd
 o
f o
ne
 tr
ia
l i
n 
he
al
th
y 
ad
ul
ts
 (O
xf
or
d 
et
 a
l.,
 2
00
3)
. 
Sp
ea
rm
an
 rh
o 
co
rr
el
at
io
n=
0.
68
 –
 0
.9
0 
w
ith
 tw
o 
w
ee
ks
 in
te
rv
al
 in
 a
 g
ro
up
 o
f 
ch
ro
ni
c 
st
ro
ke
 p
at
ie
nt
s (
H
el
le
r e
t a
l.,
 
19
87
). 
In
te
r-
ra
te
r r
el
ia
bi
lit
y:
 
r=
0.
98
4 
fo
r t
he
 d
om
in
an
t h
an
d 
an
d 
r=
0.
99
3 
fo
r t
he
 n
on
-d
om
in
an
t h
an
d 
in
 
he
al
th
y 
ad
ul
ts
 (O
xf
or
d 
et
 a
l.,
 2
00
3)
. 
Sp
ea
rm
an
 rh
o 
co
rr
el
at
io
n=
0.
83
 –
 0
.9
9 
in
 
ch
ro
ni
c 
st
ro
ke
 p
at
ie
nt
s (
H
el
le
r e
t a
l.,
 
19
87
). 
C
on
st
ru
ct
 v
al
id
ity
: 
M
ea
su
re
s r
ec
ov
er
y 
of
 a
rm
 fu
nc
tio
n 
af
te
r 
st
ro
ke
. I
s m
os
t s
en
si
tiv
e 
to
 c
ha
ng
e 
at
 th
e 
m
id
dl
e 
an
d 
up
pe
r r
an
ge
 o
f r
ec
ov
er
y 
(H
el
le
r e
t a
l.,
 1
98
7;
 P
ar
ke
r e
t a
l.,
 1
98
6)
. 
 
IV
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 V
al
id
ity
 e
st
im
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es
 
 Pa
pe
r 
W
ol
f m
ot
or
 
fu
nc
tio
n 
te
st
 
(W
M
FT
)  
To
 a
ss
es
s 
up
pe
r 
ex
tre
m
ity
 
m
ot
or
 
fu
nc
tio
n 
Pe
rf
or
m
an
ce
 
tim
e 
(p
t):
 m
ea
n 
tim
e 
to
 p
er
fo
rm
 
15
 m
ot
or
 ta
sk
s 
(s
ec
on
ds
) 
Fu
nc
tio
na
l 
ab
ili
ty
 (f
a)
: 
m
ea
n 
sc
or
e 
of
 
15
 m
ot
or
 ta
sk
s, 
ra
te
d 
on
 a
 1
-6
 
sc
al
e 
Te
st
-r
et
es
t r
el
ia
bi
lit
y:
 
r=
0.
90
 in
 a
 g
ro
up
 o
f c
hr
on
ic
 st
ro
ke
 
pa
tie
nt
s o
n 
W
M
FT
 (p
t).
 r=
0.
95
 in
 a
 
gr
ou
p 
of
 c
hr
on
ic
 st
ro
ke
 p
at
ie
nt
s o
n 
W
M
FT
 (f
a)
 (M
or
ris
 e
t a
l.,
 2
00
1)
. 
 In
te
r-
ra
te
r r
el
ia
bi
lit
y:
 
IC
C
 (2
.1
) =
 0
.9
7 
in
 p
at
ie
nt
s w
ith
 c
hr
on
ic
 
st
ro
ke
 o
n 
W
M
FT
 (p
t).
 IC
C
 (2
.1
) =
 0
.8
8 
in
 p
at
ie
nt
s w
ith
 c
hr
on
ic
 st
ro
ke
 o
n 
W
M
FT
 (f
a)
 (M
or
ris
 e
t a
l.,
 2
00
1)
. 
 
C
on
st
ru
ct
 v
al
id
ity
:  
C
an
 d
iff
er
en
tia
te
 th
e 
m
or
e 
af
fe
ct
ed
 
ex
tre
m
ity
 fr
om
 e
ith
er
 e
xt
re
m
ity
 o
f 
in
di
vi
du
al
s w
ith
ou
t i
m
pa
irm
en
t (
W
ol
f e
t 
al
., 
20
01
). 
H
ig
h 
co
rr
el
at
io
n 
be
tw
ee
n 
W
M
FT
 (p
t) 
an
d 
FM
A
 a
nd
 b
et
w
ee
n 
W
M
FT
 (f
a)
 a
nd
 
FM
A
 in
 a
 g
ro
up
 o
f p
at
ie
nt
s w
ith
 
su
ba
cu
te
 st
ro
ke
 (A
ng
 &
 M
an
, 2
00
6)
. 
W
M
FT
 (p
t) 
cl
as
si
fie
d 
86
.7
%
 o
f o
rig
in
al
 
gr
ou
pe
d 
ca
se
s i
nt
o 
th
e 
co
rr
ec
t g
ro
up
in
gs
 
(A
ng
 &
 M
an
, 2
00
6)
. 
  
II
I 
In
st
ru
m
en
ta
l A
ct
iv
iti
es
 o
f D
ai
ly
 L
iv
in
g 
 
 
 
M
ot
or
 a
ct
iv
ity
 
lo
g 
(M
A
L)
 - 
30
 
ite
m
 v
er
si
on
 
To
 m
ea
su
re
 
en
ha
nc
ed
 
qu
al
ity
 a
nd
 
qu
an
tit
y 
of
 
pa
rti
ci
pa
tio
n 
of
 th
e 
af
fe
ct
ed
 a
rm
 
in
 a
ct
iv
iti
es
 
of
 d
ai
ly
 
liv
in
g 
af
te
r 
C
IM
T.
 
M
ea
n 
sc
or
e 
of
 
qu
al
ity
 o
f 
m
ov
em
en
t 
(q
om
) o
r m
ea
n 
sc
or
e 
of
 a
m
ou
nt
 
of
 u
se
 (a
ou
) o
f 
30
 fu
nc
tio
na
l 
ite
m
s, 
ra
te
d 
on
 
a 
0-
5 
sc
al
e 
Te
st
-r
et
es
t r
el
ia
bi
lit
y:
  
IC
C
 (3
.1
) r
an
gi
ng
 fr
om
 0
.4
0 
to
 0
.7
6 
in
 
28
 o
f t
he
 3
0 
ite
m
s o
n 
M
A
L 
(q
om
), 
an
d 
IC
C
 (3
.1
) r
an
gi
ng
 fr
om
 0
.4
4 
to
 0
.6
8 
in
 
28
 o
f t
he
 3
0 
ite
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4.6 Sample size estimation (Paper I - IV) 
 
No power calculations were performed in any of the present studies. According to the ESD 
trial, we knew from the Trondheim study that a sample size of 320 patients was needed with a 
15 % rate of success on the Modified Rankin Scale, using a significance level of 0.05 and 
power of 80 % (Fjærtoft, 2005). It was unrealistic to include this number of patients from our 
study population, so we included as many patients as possible within the time limits of the 
trial, with the intention of undertaking a methodologically robust study which could also be 
included in meta-analyses. With a view to the CIMT trial, we knew from other trials that the 
number of eligible patients would be low. In addition, no minimal clinically important 
difference for our primary outcome measure, the Wolf Motor Function Test, has been 
reported. Based on this we decided to design a trial with high internal validity and to include 
as many patients as possible within the time limit of the trial, with the intention of assessing 
both the effect and the feasibility of this intervention. In Paper IV we based our sample size 
estimation on the number of patients usually included in fMRI studies in order to perform a 
random effect study. However, economic resources and the availability of eligible patients 
also influenced the number included. 
 
4.7 Study design for the ESD trial (Paper I and II) 
 
The ESD trial was a clinical randomised trial. The flow of patients through the trial is 
illustrated in Figure 4. 
 
4.7.1 Randomisation  
 
Patients fulfilling the inclusion criteria were included, and were block randomised in blocks 
of four, six or eight patients, to either a standard service or the newly devised ESD service. 
The order of the blocks was randomly chosen. Sealed opaque envelopes were used for 
randomisation and the procedure was carried out by an external office.  
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 Not randomised 
n=27 
• SSS score=2, n=5 
• SSS score>57, n=3 
• Onset of symptoms>7 days before inclusion, n=2 
• Already included in the trial, n=3 
• Admitted from institutional care, n=5 
• No informed consent, n=2 
• Not included because of holiday or other reasons, 
n=7 
Randomised 
n=62 
ESD service 
n=31 
Standard service  
n=31 
6 weeks follow-up 
*2 died within 6 weeks  
 
Analysed in Paper I: n=31, Analysed in Paper II: n=29 
6 weeks follow-up 
*1 died within 6 weeks  
*1 withdrew from the study within 6 weeks 
Analysed in Paper I: n=31, Analysed in Paper II: n=29 
26 weeks follow-up 
*8 died within 26 weeks 
 
Analysed in Paper I: n=31, Analysed in Paper II: n=23 
26 weeks follow-up 
*1 died within 26 weeks  
*2 withdrew from the study within 26 weeks 
Analysed in Paper I: n=31, Analysed in Paper II: n=28 
52 weeks follow-up 
*8 died within 52 weeks 
 
 
Analysed in Paper I: n=31, Analysed in Paper II: n=23 
52 weeks follow-up 
*4 died within 52 weeks  
*2 withdrew from the study within 52 weeks  
*2 lost to follow-up because of illness within 52 weeks 
One week follow-up 
n=31 
 
Analysed in Paper II: n=31 
One week follow-up 
*1 missed for follow-up within one week 
*2 lost to follow-up because of illness within one week 
Analysed in Paper II: n=28 
Analysed in Paper I: n=31, Analysed in Paper II: n=23 
Patients living in the municipality of Malvik, Melhus and 
Klæbu with acute stroke admitted to the Stroke Unit 
n=89 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Study design and the flow of patients through the ESD trial 
 
 
4.7.2 Blinding 
 
An independent and blinded assessor specially trained in the use of all the outcome measures 
performed the assessments in the patients’ home. However, the patients were not blinded to 
the allocated treatment and therefore this was a single blinded trial.  
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4.8 Study design for the CIMT trial (Paper III) 
 
The CIMT trial was a clinical randomised trial with pre- and post-treatment assessment, and 
six moths follow-up. The flow of patients through the trial is illustrated in Figure 5. 
 
Allocated to 2 weeks of CIMT 
(n=18) 
Received 2 weeks of CIMT 
(n=18) 
Enrollment 
n=30 
Pre-treatment assessment 
(n=30)
Allocated to standard 
rehabilitation (n=12) 
Received standard 
rehabilitation (n=12) 
Randomisation 
(n=30) 
Post-treatment assessment (n=18) 
Lost to post-treatment 
assessment (n=0) 
Post-treatment assessment (n=12) 
Lost to post-treatment assessment 
(n=0) 
Follow-up 
6 months follow-up (n=18) 
Lost to follow-up 
 (n=0) 
6 months follow-up (n=12) 
Lost to follow-up  
(n=0) 
Analysed (n=18) 
Excluded from analysis (n=0) 
Analysed (n=12) 
Excluded from analysis (n=0) 
6 months 
follow-up 
Analysis 
Patients with subacute or 
chronic stroke screened for 
inclusion 
 
Figure 5. Study design and the flow of patients through the CIMT trial 
 
4.8.1 Randomisation 
 
Patients fulfilling the inclusion criteria were included and block-randomised into a CIMT 
group or a control group receiving standard rehabilitation, according to a 3:2 ratio. This ratio 
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was chosen to assess the feasibility of CIMT for as many patients as possible. Sealed opaque 
envelopes were used for randomisation and the procedure was carried out by an external 
office.  
 
4.8.2 Blinding 
 
Two independent assessors, blinded to treatment assignment, performed all the assessments in 
a test laboratory at the hospital. The patients were not blinded to the allocated treatment, and 
consequently this was a single blinded trial. 
 
4.9 Study design for the fMRI study (Paper IV) 
 
The fMRI study was a longitudinal study with baseline assessment and three months follow-
up. The flow of patients through the study is illustrated in Figure 6. 
 
Initial Scandinavian Stroke Scale score, Oxfordshire classification (Bamford et al., 1991) and 
co-morbidity were recorded at inclusion. Motor function and disability were scored using a 
range of outcome measures (see Table 3) in the acute phase, four to seven days after stroke 
onset, and in the chronic phase, three months later. Functional MRI scanning was performed 
at the same time points. 
 
The motor task applied during the fMRI scanning was thumb-index finger opposition at self-
paced maximal rate (SP task) performed with the affected hand. Before imaging, the task was 
explained and subsequently performed by the patient to ensure full compliance. Patients’ arms 
were positioned with both forearms resting on their abdomen. An experienced observer 
registered finger movement frequency and assessed the degree of associated arm and mirror 
movements during fMRI. The motor task was visually cued on a screen at the bore opening. 
Each task was performed alternating between 29 seconds rest, i.e. fixation, and 29 seconds 
activation, i.e. SP task, with a total of five baseline and four activity epochs.  
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Patients with first-ever stroke 
admitted to the Stroke Unit screened 
for inclusion 
n = 359 
 
 
 
 
Inclusion 
n=14 
Acute phase  
(4-7 days after stroke) 
fMRI  
Clinical assessment 
n=14 
Chronic phase  
(3 months after stroke) 
fMRI 
Clinical assessment 
n=13 
Excluded: 
- Age above 75 years, n = 182 
- Intracerebral hemorrages, n = 36 
- No hand or arm paresis, n = 58 
- Total hand paralysis, n = 21 
- Admitted to the stroke unit > 48 hours after 
onset of symptoms, n = 17 
- Other diseases, n =9 
- Could not cooperate or tolerate fMRI/refused 
to participate, n = 12 
- Missed for inclusion, n = 10 
Withdrawn 
n=1 
Analysed 
n=12 
fMRI failed because of technical problems 
n=1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Study design and the flow of patients through the fMRI study 
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 4.10 Analysis 
 
A p-value < 0.05 was considered significant in all analysis. Analysis of all clinical data has 
been carried out in SPSS 13.0 (SPSS inc, USA), while image data was analysed using 
statistical parametric mapping 5 (SPM5, Wellcome Department of Imaging Neuroscience, 
http://www.fil.ion.ucl.ac.uk/spm/) running on MatLab 6.5.1 (The Mathworks Inc., USA). 
Different statistical approaches have been used in the different papers and will be described in 
the following sections. 
 
4.10.1 Baseline assessments 
 
At baseline, the distribution of gender, medical history, living conditions, diagnosis, side 
affected and home community were compared with the Chi-square test or Fisher’s Exact Test 
when appropriate. The differences in severity of stroke according to Scandinavian Stroke 
Scale, Barthel Index, Modified Rankin Scale scores and months since stroke were analysed 
with the Mann-Whitney U-test. The difference in age was analysed with the t-test for 
independent samples. 
  
4.10.2 Follow-up assessments 
 
Intention to treat analysis 
Intention to treat analysis is a strategy for the analysis of randomised controlled trials which 
compares patients in the groups in which they were originally randomly assigned. This is 
generally interpreted as including all patients, regardless of whether they actually satisfied the 
entry criteria, the treatment actually received, and subsequent withdrawal or deviation from 
the protocol (Hollis & Campbell, 1999). However, there is no precise answer as to how one 
should impute missing data from patients who drop out or die during the trial. Sophisticated 
imputation methods are merely devices for facilitating the final analysis. They are no 
substitute for the real data (Fayers & Machin, 2000). Intention to treat analysis was used in all 
analysis on the Modified Rankin Scale and Barthel Index (Paper I), and Wolf Motor Function 
Test, Motor Activity Log, Functional Independent Measure and Stroke Impact Scale (Paper 
III). Missing data from Modified Rankin Scale and Barthel Index were gathered by using all 
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available information including baseline assessment and information from readmission to the 
hospital. There were no dropouts or missing data in the CIMT trial.  
 
Per protocol analysis 
Per protocol analysis is the opposite alternative to intention to treat analysis, where only those 
who satisfy the entry criteria of the trial and who subsequently adhere to the protocol are 
analysed. However, clinical effectiveness may be overestimated by such analysis, which may 
yield systematic errors in the data (May et al., 1981). Per protocol analysis was performed on 
the Nottingham Health Profile, Caregiver Strain Index and average Barthel Index score in 
Paper I, and Berg Balance Scale and fast walking speed in Paper II.  
 
Analysing group differences 
Differences between the groups in the proportion of patients independent and deceased were 
compared by the Fisher’s Exact Test. The Nottingham Health Profile, Caregiver Strain Index, 
Berg Balance Scale, average Barthel Index score and length of stay, were compared by the 
Mann-Whitney U-test. The fast walking speed was compared using student t-test for 
independent samples. 
 
In small randomised controlled trials there is an increased risk for imbalance between the 
groups at baseline. This was the case in Paper I, Paper II and Paper III. Different statistical 
approaches are available to adjust for these differences (Vickers & Altman, 2001).  
 
Paper I: Multiple logistic regression was used to obtain a more precise estimate of the 
dichotomised Modified Rankin Scale score (primary outcome) adjusting for potential 
confounders such as stroke severity measured by Scandinavian Stroke Scale score, age and 
living conditions (Kleinbaum 2002). Age was dichotomised at the median, Scandinavian 
Stroke Scale was entered in the model as a continuous variable, and living condition was 
categorised as living alone or not. 
 
Paper II: The Berg Balance scale did not fulfil the assumption of normal distribution by 
inspection of Quantile-Quantile plots, and consequently no parametric tests could be used. In 
this case we chose to compare the change score to adjust for the initial imbalance. The Mann-
Whitney U-test was used to analyse the difference in change. A similar approach was chosen 
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for walking speed; however, due to normal distribution, the student t-test for independent 
samples was chosen as the statistical method. 
 
Paper III:  Normal distribution assumptions were checked by visual inspection of Quantile-
Quantile plots for all outcome measures in Paper III. Wolf Motor Function Test, performance 
time, had a skewed distribution and a logarithmic transformation was performed. In the 
statistical tests the transformed scale was used as a test parameter, but in the summary 
statistics, the log transformed scale was transformed back to its original scale to aid in 
interpretation. Differences between groups were analysed with analysis of covariance 
(ANCOVA) with the baseline score of the dependent variable as a covariate (Vickers & 
Altman, 2001). In a second-level analysis it was adjusted for age, gender, time from onset of 
stroke and dominant side affected (Pocock et al., 2002).  
 
Analysing change within groups 
Changes within groups were calculated by subtracting the follow-up score from the baseline 
score. The change score were analysed by Wilcoxon Signed Rank Test for Berg Balance 
Scale (Paper II), Scandinavian Stroke Scale, Barthel Index, Modified Rankin Scale and Motor 
Assessment Scale (Paper IV) or paired t-test for walking speed (Paper II), self-paced tapping 
rate, log transformed Nine Hole Peg Test, transversal grip strength and key grip strength 
(Paper IV).   
 
Analysing association of function 
Multiple logistic regression was used to analyse the association between initial leg paresis and 
initial movement ability as independent variables, and the dichotomised Berg Balance Scale 
score 52 weeks after stroke as the dependent variable, allowing adjustments for potential 
confounders such as age, gender, treatment group and number of days from onset of 
symptoms to hospital admission 
 
Analysing functional MRI data 
Functional MRI data was analysed using Statistical Parametric Mapping 5 (SPM5) running on 
MATLAB 6.5.1. A region of interest (ROI) consisting of the entire pre- and post-central gyri 
including primary motor cortex (MI), secondary motor cortex (MII), primary somatosensory 
cortex (SI), somatosensory association cortex, secondary somatosensory cortex (SII), plus the 
entire cerebellum, bilateral thalami, caudate nuclei, putamen and globus pallidi, 
 57
supplementary motor area (SMA), rostral inferior parietal lobe (IPL) and insula was drawn in 
MNI space using the software MRIcro.  
 
Images for patients with right-sided infarctions were flipped. Group activation maps for acute 
and chronic phases were determined with a one-sample t-test using false discovery rate (FDR) 
set to FDR<0.05 (Genovese et al., 2002). Cluster size was 15 voxels. A paired t-test was used 
to test for differences between the acute and chronic phases, and in a covariate analysis 
regions positively co-varying with changes in the functional motor score between acute and 
chronic phases were assessed. Due to the small number of patients and the specific 
hypothesis, a more lenient statistical threshold (p<0.01, uncorrected) was applied in these 
analysis. 
 
Based on the number of activated voxels in the different ipsilesional (I) and contralesional (C) 
cortical ROIs defined from the fMRI images, a Lateralisation Index (LI) was calculated 
according to the equation: (I-C)/(C+I) for the cerebral and (C-I)/(C+I) for the cerebellar 
hemisphere. The LI was calculated for MISI, MIISII, IPL, insula and cerebellum. The index 
ranges from 1 to -1. LI=1 means all activated voxels in the ipsilesional cerebral and 
contralesional cerebellar hemisphere, while LI=-1 means all activated voxels in the 
contralesional cerebral and ipsilesional cerebellar hemisphere. 
 
All analyses of image data were performed by co-workers at the Department of Circulation 
and Medical Imaging. The analyses are described in detail in Paper IV.  
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5 Synopsis 
 
5.1 Paper I 
 
Evaluation of an extended stroke unit service with early supported discharge for patients 
living in a rural community. A randomised controlled trial 
An extended stroke unit service with ESD was beneficial for patients living in the city of 
Trondheim. The aim of the present trial was to evaluate the effect of an equivalent ESD 
service for patients living in a rural community. A randomised controlled trial was designed to 
compare a newly constructed ESD service with the standard and well documented service. 
Sixty-two eligible patients with acute stroke living in the municipalities of Malvik, Melhus 
and Klæbu were included in the trial. Thirty-one patients were allocated to the standard 
service, and thirty-one patients were allocated to the ESD service with further rehabilitation 
co-ordinated by a multidisciplinary mobile team in close cooperation with the primary health 
care system. The results showed that 12 patients (39%) in the ESD group versus 16 patients 
(52%) in the standard service group were independent according to the Modified Rankin 
Scale 52 weeks after onset of stroke (p=0.444). The odds ratio for independence (ESD service 
versus standard service) was 0.33 (95% confidence interval; 0.088 – 1.234). According to the 
Nottingham Health Profile, the ESD service group showed a significant lower score (better 
outcome) on the social isolation item compared to the standard service group (p=0.045). 
Otherwise there were no significantly differences according to the Nottingham Health Profile, 
Barthel Index, Caregiver Strain Index, length of stay or mortality. An ESD service for patients 
living in the rural community seems to have no influence on death or dependency but might 
indicate a trend towards less social isolation. However, the sample size was too small to yield 
any definite conclusion. 
 
5.2 Paper II 
 
Does an extended stroke unit service with early supported discharge have any effect on 
balance or walking speed? 
Our ESD trial did not show any beneficial effect according to the primary outcome measure. 
However, it cannot be precluded that the intervention might demonstrate beneficial effects 
according to a more sensitive outcome scale. The early discharge with focus on rehabilitation 
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in the patient’s home might have an impact on functional balance. The aim of Paper II was to 
use secondary data from the ESD trial to evaluate whether the ESD service had any effect on 
balance or walking speed. An additional aim was to explore the association between initial leg 
paresis, initial movement ability and balance one year after stroke. Per protocol analysis was 
performed, identifying different numbers of patients in each group at baseline and follow-up. 
The results showed no significant differences between the groups according to Berg Balance 
Scale or fast walking speed despite a significant faster walking speed (p=0.043) in the 
standard service group at one week post stroke. Only those cases with all assessments 
available were analysed for change within the groups. This results showed a significant 
improvement on the Berg Balance Scale from one week to six weeks follow-up (p=0.013) and 
a significant improvement in fast walking speed from one week to six weeks follow-up 
(p=0.022), from one week to twenty-six weeks follow-up (0.044) and from one week to fifty-
two weeks follow-up (p=0.028) in the ESD group. There was no significant improvement in 
the standard service group at the same time point. However, when the change scores were 
compared there was only a trend (p=0.065) in favour of better balance in the ESD group from 
one week to six weeks follow-up. All patients with initial severe leg paresis suffered from 
poor balance one year after the stroke, but there was no association between moderate paresis 
and poor balance at the same time. The odds ratio (95 % confidence interval (CI)) for poor 
balance was 42.1 (3.5 – 513.9) among patients with no initial walking ability and 4.6 (0.8 – 
26.5) among patients walking with support. An ESD service for patients living in the rural 
community seems to have no influence on balance or walking speed. However, the non-
significant trend toward greater change on the Berg Balance Scale from one week to six 
weeks follow-up in the ESD group indicates a possible effect on balance for early 
rehabilitation in the patients’ home. The study revealed a strong association between initial 
severe leg paresis, but not between initial moderate leg paresis, and poor balance one year 
after the stroke. There was also a strong association between initial inability to walk and poor 
balance, while the odds ratio for poor balance among patients who initially walked with 
support was weaker. 
 
5.3 Paper III 
 
Short and long term outcome of Constraint-Induced Movement Therapy after stroke. 
A randomised controlled feasibility trial 
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Constraint-Induced Movement Therapy (CIMT) belongs to a group of therapies that aims to 
permanently increase the amount of use and quality of movement of a paretic upper extremity 
following stroke. The majority of CIMT trials have been conducted in the US, and few have 
been published from Europe. The primary aim of this trial was to assess the effect of CIMT 
compared to standard rehabilitation, in the short and long term, considering arm motor 
function, independence in ADL and self-perceived health in patients after stroke. A secondary 
aim was to assess the feasibility of CIMT, organised as group therapy in the Norwegian 
healthcare system. A randomised controlled trial was designed to compare ten days of CIMT 
organised at an in-patient rehabilitation clinic with standard rehabilitation. Thirty patients 
with unilateral hand impairment after stroke were included. Eighteen patients were allocated 
to six hours of arm therapy for 10 consecutive weekdays while using a restraining mitten on 
the unaffected hand for 90 % of their waking hours, and twelve patients were allocated to 
standard rehabilitation. The results showed a statistically significant shorter performance time 
(4.76 seconds versus 7.61 seconds, p=0.030) and greater functional ability (3.85 versus 3.47, 
p=0.037) according to the Wolf Motor Function Test (primary outcome) in the CIMT group 
compared to the control group at post-treatment assessment. There was a non-significant trend 
toward greater amount of use (2.47 versus 1.97, p=0.097) and better quality of movement 
(2.45 versus 2.12, p=0.105) in the CIMT group according to the Motor Activity Log. No such 
differences were seen on the Functional Independent Measure. At 6 months follow-up the 
CIMT group maintained their improvement, but as the control group also improved during the 
follow-up period, there were no significant differences between the groups on any 
measurements. From the present trial we can conclude that CIMT seems to be an effective 
method to improve motor function in the short term, and it was feasible to organise CIMT as 
group therapy for this selected group of patients. However, no long-term effect was found and 
it is still unclear to what extent the functional improvement after CIMT is ultimately 
beneficial for activities of daily living.  
 
5.4 Paper IV 
 
Motor network changes associated with successful motor skill relearning in patients with 
acute stroke. A longitudinal functional MRI study 
In most stroke patients, recovery follows an exponential progression, with a fast initial 
improvement in the first six weeks, and a slower recovery for the next six weeks. Many 
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functional MRI studies have been undertaken in the past decade to study the role of brain 
plasticity in the recovery after stroke. The aim of the present study was to assess the early 
motor network changes in a group of stroke patients treated in a comprehensive stroke unit 
with ESD and further follow-up coordinated by a multidisciplinary team using a task-oriented 
approach, and to investigate its relationship to motor learning. Twelve patients with the 
diagnosis of first-ever stroke, who were admitted to the Stroke Unit at St. Olavs Hospital and 
fulfilled the inclusion criteria, were assessed with functional MRI and clinical tests within one 
week after stroke and three months later. The results showed significant improvement in 
terms of all functional outcome measures (SSS, BI, mRS, UL-MAS, NHPT, transversal grip 
strength, and key grip strength). All patients except one had complete recovery of the affected 
arm/hand as measured by UL-MAS. Increased activation in secondary sensorimotor areas 
(ipsilesional angular gyrus and insula, bilateral putamen and contralesional cerebellum) was 
revealed in the acute phase compared to the chronic phase. The chronic phase demonstrated 
higher activation in the ipsilesional hand motor area (MISI), corresponding to restored 
laterality of the primary motor network, in addition to increased bilateral activity in the 
somatosensory association area plus increased contralesional activity in the secondary 
somatosensory area (SII). The contralesional SII activation correlated positively with 
improvement in dexterity as measured by UL-MAS and NHPT, and transversal grip strength, 
as well. The observed changes in activation pattern from the acute to the chronic phases are 
comparable to changes described in motor learning studies, while the recruitment of bilateral 
somatosensory association areas and contralesional SII is considered to represent cortical 
plasticity involved in successful relearning of motor skills after stroke.  
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6 Discussion 
 
6.1 The main result of the thesis 
 
This thesis has revealed that the ESD service did not significantly influence death or 
dependency, balance or walking speed for patients living in a rural community. However, it 
may lead to less isolation and a transient improvement in self-percieved health. The thesis has 
also revealed that CIMT organised as group therapy is feasible and efficient in the short term 
but may not be superior to standard rehabilitation in the long term. Finally, the thesis has 
shown that the motor network changes associated with successful motor recovery are 
comparable to changes described in motor skill learning in healthy subjects. These changes 
involve restoration of the lateralised primary motor network in addition to increased 
recruitment of bilateral somatosensory association areas and increased contralesional SII 
activation. 
 
6.2 Comparing the ESD trial with other studies 
 
Nine randomised trials evaluating an ESD service for stroke patients were published before 
our trial. Of these, two trials had no multidisciplinary team (Suwanwela et al., 2002; Ronning 
& Guldvog, 1998) while seven trials evaluated an ESD service organised by a 
multidisciplinary team (Rudd et al., 1997; Rodgers et al., 1997; Widen et al., 1998; Bautz-
Holtert et al., 2002; Anderson et al., 2000; Mayo et al., 2000; Indredavik et al., 2000). A 
recent update identified a new ESD trial with a multidisciplinary team (Donnelly et al., 2004). 
Our trial will be discussed in the light of the eight trials with comparable interventions listed 
in Table 4. 
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Table 4. Trials which have compared the effect of early supported discharge for acute stroke 
patients versus conventional care. Odds ratio (OR) and 95% confidence interval (CI) for death 
and dependency at end of follow-up (Early Supported Discharge Trialists, 2007; Langhorne & 
Holmqvist, 2007). 
 
Study 
Treatment 
n/N 
Control 
n/N 
 
OR (95% CI) 
Adelaide (Anderson et al., 2000) 13/42 16/44 0.78 (0.32 – 1.92) 
Belfast (Donnelly et al., 2004) 29/59 32/54 0.66 (0.32 – 1.40) 
London (Rudd et al., 1997) 105/167 109/164 0.85 (0.54 – 1.34) 
Montreal (Mayo et al., 2000) 17/58 24/56 0.55 (0.25 – 1.20) 
Newcastle (Rodgers et al., 1997) 22/46 28/46 0.59 (0.26 – 1.35) 
Oslo (Bautz-Holtert et al., 2002) 16/42 17/40 0.83 (0.34 – 2.01) 
Stockholm (Widen et al., 1998) 9/42 12/41 0.66 (0.24 – 1.79) 
Trondheim 2000 (Indredavik et al., 2000) 64/160 81/160 0.65 (0.42 – 1.01) 
Trondheim 2004 (Askim et al., 2004) 19/31 15/31 1.69 (0.62 – 4.63) 
 
6.2.1 Setting 
 
Our multidisciplinary team was based within the stroke unit and included a nurse, a 
physiotherapist, an occupational therapist and the consulting service of a physician. This is in 
accordance with the trials from Oslo (Bautz-Holtert et al., 2002), Stockholm (Widen et al., 
1998), and Trondheim (Indredavik et al., 2000). The five remaining trials had community-
based inreach teams (contacted patients prior to discharge) well-informed about the local 
services (Rudd et al., 1997; Rodgers et al., 1997; Anderson et al., 2000; Mayo et al., 2000; 
Donnelly et al., 2004). Langhorne et al (2005) have shown that trials with hospital outreach 
teams have better outcomes than trials with community inreach teams. The hospital-based 
setting is in our view an important factor for a successful ESD service, although this is not 
demonstrated in our trial. Within this setting, it is possible for the team to start collecting 
information about the patient immediately after admission to the stroke unit, and to establish 
close cooperation between the patient, the family, and the staff during the hospital stay. The 
team also made plans for the discharge and further follow-up in close cooperation with the 
primary health care system during the in-patient period.  
 
All of the comparable trials, except our ESD trial, have so far been conducted within urban 
centres. Three municipalities neighbouring the city of Trondheim are defined in this trial as 
the rural setting. However, it may be disputed whether this area is rural or not. The population 
density was about 31 inhabitants per square kilometres within our rural area, indicating a 
disperse settlement compared to 446 inhabitants per square kilometres within the city of 
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Trondheim. However, some of the areas within the municipality of Malvik, Melhus and 
Klæbu had a settlement pattern more resembling a suburb of Trondheim.  
 
In conclusion, our hospital-based multidisciplinary team is comparable to that in three other 
ESD trials, while our trial is so far the only trial within a rural setting. This makes it 
somewhat difficult to compare our results with other trials and may also explain why our 
results differ from those of the other trials. This will be further discussed in section 6.2.4.  
 
6.2.2 Study patients 
 
Our inclusion criteria targeted all patients with acute stroke who were conscious at inclusion 
and who were independent before the stroke. Based on these criteria, we included 70 % of 
those patients admitted to the stroke unit from the municipalities of Malvik, Melhus and 
Klæbu. The mean age was 77 years in the treatment group and 76 years in the control group, 
while the median Barthel Index at baseline was 55/100 in both groups. The typical population 
included in other ESD trials had a median Barthel Index at randomisation of 70/100, while the 
mean or median age in these trials ranged from 68 to 78 years (Langhorne et al., 2005). Our 
unselected group of patients is more disabled compared to this typical population, and also 
compared to patients included in the Trondheim trial (Indredavik et al., 2000). Subgroup 
analysis has shown that patients with initially moderate disability (Barthel Index of 50 - 100) 
appear to benefit best from ESD services (Langhorne et al., 2005), indicating that the most 
severely disabled patients may not have the capability to utilise the coordinated ESD service.  
 
In conclusion, our patients were more disabled than patients in other comparable ESD trials, 
which may also partly explain why our ESD trial not replicated the benefits of this treatment 
demonstrated in most other studies.  
 
6.2.3 Study intervention 
 
Three different subtypes of ESD interventions are described (Early Supported Discharge 
Trialists, 2007): (1) ESD team co-ordination and delivery, which implies a co-ordinated 
multidisciplinary ESD team that co-ordinates and provides post-discharge care; (2) ESD team 
co-ordination, which implies a co-ordinated multidisciplinary ESD team which co-ordinates 
and supervises discharge and immediate post-discharge care, but then hands over the 
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responsibility to other services; and (3) no ESD team, which implies that post-discharge 
services are not provided by a co-ordinated multidisciplinary ESD team. Our study 
intervention is described as ESD team co-ordination in line with the trials from Trondheim 
and Oslo (Langhorne & Holmqvist, 2007).  
 
The aim of Paper I was to evaluate the effect of the ESD service, tested out in the Trondheim 
trial, for patients living in a rural community. Due to the distance between the hospital and the 
three rural municipalities some minor changes in the features of the extended service were 
made. However, the study interventions are still comparable.  
 
The multidisciplinary team is regarded as a significant component of the ESD service, as most 
of the evidence of benefit of ESD services comes from trials implementing specialist 
multidisciplinary team which work is coordinated through regular meetings (Langhorne et al., 
2005). ESD trials with no ESD team have shown a non-significant trend toward increased 
death and dependency (Langhorne & Holmqvist, 2007). This result supports the importance 
of the ESD team coordination. 
 
Another important component of the ESD service may be the emphasis on early and intensive 
task-oriented exercise therapy in the patients’ home coordinated by the team member, but 
conducted by the primary health care providers. This is in contrast to most other trials in 
which the ESD team also delivered the post-discharge care (Anderson et al., 2000; Rudd et 
al., 1997; Mayo et al., 2000; Rodgers et al., 1997; Widen et al., 1998; Donnelly et al., 2004). 
Whether the early training in the patients’ home is delivered by the team member or the 
primary health care provider may not be the main issue. Both alternatives might be beneficial, 
depending on how the local services are organised. However, it may be important that the 
training is given at a particular level according to the patients’ individual needs.  
 
In conclusion, our study intervention is comparable to other ESD trials with team 
coordination. However, there is no evidence for this alternative being superior to ESD team 
coordination and delivery. 
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6.2.4 Results 
 
The primary outcome of Paper I was the dichotomised Modified Rankin Scale (mRS ≤ 2) 
showing a non-significant trend toward better outcome in the control group. This is in contrast 
to all other comparable ESD trials. The latest ESD meta-analysis (Figure 7), including both 
published and unpublished individual data, showed reduced death and dependency for 
patients receiving ESD after stroke (Langhorne & Holmqvist, 2007). Among these trials the 
Trondheim trial is the most convincing, showing a significantly higher proportion of 
independent patients in the ESD group at six months follow-up (Indredavik et al., 2000) and 
one year after the stroke (Fjaertoft et al., 2003). There may be several reasons why our trial 
did not replicate this result. Firstly, collapsing the data into the dichotomised Modified Rankin 
Scale generally lowers statistical power and reduces the chance of finding a significant 
treatment effect because information from many subjects is ignored. For example, patients 
responding to treatment with an improvement from 4 to 3 points are ignored in an analysis on 
the dichotomised scale (Bath et al., 2007). This reduces the chance of detecting significant 
differences especially in trials with small sample sizes. The rural setting implies a small 
number of inhabitants and consequently difficulties in including sufficient numbers of patients 
to comply with sample size estimates. However, it is still important to perform small trials 
with high internal validity which can be included in Cochrane Reviews or other meta-
analysis. The methodological robustness of the present trial is confirmed by the inclusion of 
the trial in the latest ESD meta-analysis by Langhorne & Holmquist (2007). Secondly, our 
trial is so far the only ESD trial conducted for patients living in a rural community. The 
different organisation of the primary health care system, and the variation in the numbers of 
physiotherapists and occupational therapists in the urban centres and rural communities, may 
also account for the lack of benefit of our ESD service. Small communities are characterised 
by people knowing each other, and the people working in the primary health care system 
often know their patients and relatives. This may lead to closer relationship and a better 
coordinated standard service. Consequently, the difference between the ESD service and the 
standard service may not be as significant in the rural community as in urban centres. Thirdly, 
the small sample size may give rise to an uneven distribution of confounding factors at 
baseline. In addition, an adverse event in one of the groups will have greater impact on the 
results where there is a small sample size. The analysis on Berg Balance Scale in Paper II 
revealed a non-significant trend toward initial better balance in the control group. This finding 
supports the theory about an uneven distribution at baseline.  
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 One may question whether ESD encourages dependency, but this appears unlikely because 
the equivalent ESD service was very beneficial for patients living in the city of Trondheim 
(Indredavik et al., 2000).  
 
Figure 7. Latest update of meta-analysis on ESD trials (Langhorne & Holmqvist, 2007) 
(Printed with permission from the Early Supported Discharge Trialists) 
 
The results on the Modified Rankin Scale were confirmed by the Barthel Index. Self-
perceived health as measured by the Nottingham Health Profile revealed no significant 
differences between the groups at any time except less social isolation in the ESD group at 26 
weeks follow-up. Improved self-perceived physical health was reported in the Montreal trial 
(Mayo et al., 2000), and improved global subjective health in the Trondheim trial (Fjaertoft et 
al., 2004), but no improved self-perceived health was found in any of the other comparable 
trials (Anderson et al., 2000; Rudd et al., 1997; Rodgers et al., 1997; Bautz-Holtert et al., 
2002; Donnelly et al., 2004; Widen et al., 1998). 
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The Caregiver Strain Index was used to detect whether the ESD increases the burden on the 
caregivers. Four other trials have evaluated this aspect and found no increased burden, in line 
with the present trial (Donnelly et al., 2004; Rudd et al., 1997; Rodgers et al., 1997; Fjaertoft 
et al., 2004). However, one trial found significantly lower mental health among caregivers in 
the ESD group (Anderson et al., 2000). This last result implies that the impact of ESD on the 
caregivers’ health and well-being should be further investigated.  
 
The ESD service has been shown to be a cost-saving treatment with less use of in-patient 
rehabilitation (Anderson et al., 2002). Our trial showed a non-significant reduction of seven 
in-patient days in the ESD group, which emphasises the potential cost-saving advantage of 
this treatment. 
 
This is to our knowledge the first ESD trial reporting results on the Berg Balance Scale. The 
ordinal Berg Balance Scale has good responsiveness (Mao et al., 2002). To discover a clinical 
significant change on six Berg Balance Scale points in patients with moderate to mild stroke, 
power calculations, using a significance level on 0.05 and 90 % power, have revealed a 
sample size of 30 patients in each group. This is not so far from the number of patients 
analysed in Paper II, which strengthens the validity of these results. The between group 
analysis showed no significant differences at six, 26 or 52 weeks post stroke. However, the 
Berg Balance Scale showed a non-significant trend toward better outcome in the control 
group at one week follow-up. This difference could not be ascribed to the effect of the ESD 
service, as the intervention had not yet started at this time. To adjust for these differences, the 
change within each group on all cases completing all assessments during the one year follow-
up period was assessed and compared. The results showed an almost significant (p=0.065) 
greater improvement on the Berg Balance Scale from one to six weeks follow-up in the ESD 
group compared to the control group, indicating greater gains on balance for patients 
receiving ESD service. This result should be interpreted with caution, as the control group 
was closer to the ceiling effect on the Berg Balance Scale than the ESD group, and the low 
number of remaining participants implies that the groups may not be fully comparable at that 
stage.  
 
The walking speed did not show equally greater improvement in the ESD group, indicating 
that functional training in the patients’ home might facilitate functional balance as measured 
with the Berg Balance Scale but not fast walking speed. However, we have no detailed 
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records of the home-training programme, and it is possible that the treatment was not as 
intensive and task-specific as intended. Three other trials have also reported no differences 
between the groups according to walking speed (Rudd et al., 1997; Widen et al., 1998; 
Donnelly et al., 2004). Further research should emphasise task-specific exercise therapy with 
a higher intensity in addition to an ESD service to enhance further improvement on both 
balance and walking speed. 
 
The second aim of Paper II was to assess the association between initial leg paresis and 
balance one year after the stroke and to assess the association between initial movement 
ability and balance at one year follow-up. All four cases with initial severe leg paresis 
suffered from poor balance after one year, but there was no association between initial 
moderate paresis and balance. Those with no initial walking ability had a significantly 
increased risk of poor balance, while those walking with support showed a non-significant 
trend (p=0.085) toward poor balance at one year follow-up. As far as we know, no other 
studies have assessed an equivalent association. Balance is an important component of 
walking, and poor balance is a major cause of falls (Lord SR et al., 2001). A number of other 
studies have assessed the significance of leg paresis in predicting falls or walking function 
after stroke (Wandel et al., 2000; Olsen, 1990; Jorgensen et al., 1995a; Jorgensen et al., 2002; 
Kollen et al., 2005). The results from these studies are conflicting, showing both a strong 
association between initial severe leg paresis and poor recovery of walking function 
(Jorgensen et al., 1995a; Wandel et al., 2000), and no association between initial leg paresis 
and the risk of falling when the results were adjusted for depression (Jorgensen et al., 2002), 
and finally that improvement in standing balance control is more important than improvement 
in leg strength to achieve improvement in walking ability (Kollen et al., 2005). Our results 
indicate a strong association between initial severe leg paresis and poor balance, in line with 
two other studies (Jorgensen et al., 1995a; Wandel et al., 2000). The lack of significant 
association between initial moderate leg paresis and balance implies that moderate leg paresis 
is of minor importance for balance and walking ability after stroke, which is in line with 
Kollen et al. (2005). However, the significance of initial movement ability on balance one 
year after stroke is confirmed by a number of studies claiming the importance of trunk control 
for functional outcome after stroke (Franchignoni et al., 1997; Duarte et al., 2002; Hsieh et al., 
2002).  
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In conclusion, the main result of our ESD trial deviates from other comparable ESD trials; 
however, some of the secondary outcome measures show a slight trend toward greater 
improvement in the ESD group in line with the other trials. This deviating result is mainly 
explained by low statistical power due to the small sample size and more disabled patients in 
our trial. The rural setting may also partly explain this deviating result. 
 
6.3 Internal validity of the ESD trial 
 
Internal validity implies that the differences observed between groups of patients allocated to 
different interventions may, apart from random error, be attributed to the treatment under 
investigation. The internal validity is threatened by four categories of bias: selection bias, 
performance bias, detection bias and attrition bias (Juni et al., 2001). 
 
6.3.1 Selection bias 
 
The main reason for using randomisation is to prevent selection bias by creating groups that 
are comparable for any known or unknown potentially confounding factors (Altman & Bland, 
1999). The randomisation procedure in the present trial was carefully planned before the 
study started. Sealed opaque envelopes were used for randomisation and the procedure was 
carried out by an external office. This procedure was established practice at the time of study 
planning, with a view to avoid selection bias, although a computer-generated randomisation 
would have been preferable today.  
 
There are several prognostic baseline variables that can be potential confounders in stroke 
trials. Some of the most important are age, gender, stroke subtype, living condition and 
neurological impairment (Kapral et al., 2005; Nakayama et al., 1994; Patel et al., 2000; 
Christensen et al., 2005; Jorgensen et al., 1999); however, gender is documented both to be a 
predictor (Kapral et al., 2005) and not to be a predictor (Jorgensen et al., 1999) of recovery 
after stroke. 
 
Although none of these variables was significantly different at baseline in our trial, we cannot 
exclude the possibility that some of them may bias the result after all. Accordingly, we chose 
to adjust our primary outcome for age, living condition and neurological impairment, assessed 
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by the Scandinavian Stroke Scale, in a multiple logistic regression model. Only age and 
neurological impairment remained significant and were included in the final model.  
 
6.3.2 Performance bias 
 
Performance bias occurs if additional treatment interventions are provided preferentially to 
one group (Juni et al., 2001). All patients randomised to the ESD group and all patients 
randomised to the control group were treated according to the protocol, i.e. ESD coordination 
or standard follow-up care, respectively; however, a carry-over effect from the ESD group to 
the standard group cannot be excluded. 
 
The primary health care system upgraded their skills associated with stroke treatment through 
regular meetings with the mobile stroke team before and during the trial. A methodological 
challenge was that the same primary health care system provided services for both groups, 
while the follow-up care was coordinated by the multidisciplinary mobile stroke team only in 
the ESD group. This design increases the risk of a carry-over effect from the patients in the 
ESD group to patients in the control group. Hence, the difference between the ESD 
coordination and the standard service may not be significant any longer. The increased risk of 
performance bias in small communities with few staff in the primary health care system might 
be avoided by randomising different municipalities to different treatments. However, this 
design also has several methodological challenges. 
 
6.3.3 Detection bias 
 
Detection bias arises if the knowledge of patient assignment influences the assessment of 
outcome. This is avoided by the blinding of those assessing the outcome (Juni et al., 2001). 
The assessor in the present trial was blinded to patient assignment. It was impossible to blind 
the patients to their assignment and we cannot exclude the possibility that some of the patients 
revealed their assignment to the assessor. This might theoretically have influenced some of 
the results. However, this is not very likely according to the performance-based outcome 
measures, though it may have affected the self-reported outcome measures. Outcome 
measures used in this trial, assessed for reliability, are documented to have good test-retest 
and inter-rater reliability, which also is a prerequisite for avoiding detection bias. 
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The primary outcome in Paper I was the dichotomised Modified Rankin Scale. In addition, 
the dichotomised Barthel Index (BI≥95) and mean Barthel Index were used as secondary 
outcomes to measure independence in activities of daily living. These are the most widely 
used outcome measures in previous stroke trials (Duncan et al., 2000; Stroke Unit Trialists' 
Collaboration, 2002; Early Supported Discharge Trialists, 2007). However, both scales are 
claimed to be insensitive to small changes (Bath et al., 2007). The advantage is their 
robustness, minimising the chance of detection bias.  
 
The Berg Balance Scale and timed walking speed are both performance-based measurements 
with minimal risk of detection bias.  
 
The Nottingham Health Profile was one of the first measures to emphasise the subjective 
aspects of health assessment. The Nottingham Health Profile is short and easy to complete, 
and the wording is simple and easily understood (Fayers & Machin, 2000). However, each 
item is a negatively loaded statement, to which the patients are supposed to answer yes or no. 
Hence, the scale is focused on disability rather than ability, which may increase the risk of 
reporting poor self-perceived health. However, this problem will probably be equal for 
participants in both groups and consequently will not affect the detection bias. In recent years 
many generic and disease-specific outcome measures of self-perceived health have been 
developed. For stroke patients the Stroke Impact Scale is regarded as a reliable and valid 
measure (Duncan et al., 1999), but the responsiveness is not convincing (Salter et al., 2005c). 
Consequently, the generic Medical Outcome Study Short Form 36 (SF-36) is today the most 
frequently applied measure of self-perceived health in stroke trials (Salter et al., 2007). 
 
The carers of stroke patients experience significant strain (Robinson, 1983). In the present 
trial the Caregiver Strain Index was used to assess this aspect during follow-up. Although the 
patient allocation was known to the carers, is it unlikely that this knowledge would influence 
their response according to this measurement.  
 
6.3.4 Attrition bias 
 
Deviation from the protocol and loss to follow-up often lead to the exclusion of patients after 
they have been allocated to treatment groups, which may introduce attrition bias (Juni et al., 
2001). No patients were excluded after they had been allocated to the treatment groups. An 
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intention to treat analysis was performed according to the primary outcome measure in Paper 
I, which excludes the possibility for attrition bias. There was a 26 % death or dropout 
incidence during the 52 weeks follow-up. Eight patients died in the ESD group, and in the 
control group four patients died, two patients suffered from severe illness and two patients 
withdrew from the study. If the most severely disabled patients in the control group withdrew 
from the study, this could lead to a higher functional level among those remaining in the per 
protocol analysis, which may in turn introduce attrition bias. However, this bias goes in 
disfavour to the ESD group. 
 
In conclusion, the small sample size may have increased the risk of selection bias in our ESD 
trial. However, the possibility of performance bias and attrition bias may have influenced the 
results in disfavour of the ESD service. Finally, there is no evidence for detection bias in this 
trial. Despite these possible biases, our ESD trial is judged to have high internal validity. 
 
6.4 External validity of the ESD trial 
 
External validity of a trial is the extent to which results of the trial provide a correct basis for 
generalisation to other circumstances. The external validity comprises several dimensions.  It 
is related to the applicability of the results of a study to other “populations, settings, treatment 
variables and measurement variables”  (Juni et al., 2001). If intervention trials are judged as 
internally valid the external validity should be high. According to the small sample size in the 
present trial the external validity may be difficult to interpret. 
 
The median proportion of patients eligible for the ESD service in previous ESD trials was 
41%, indicating that this service is favourable for a selected group of stroke patients 
(Langhorne et al., 2005). However, our inclusion criteria were broad, including an unselected 
population (70 %) from three municipalities surrounding the city of Trondheim. The Stroke 
Unit had 14 available hospital beds during this trial. Patients who were admitted to other 
wards at the hospital when the Stroke Unit was full were not considered for inclusion in the 
trial. The exclusion of patients due to lack of beds could hardly have any impact on the 
external validity. The Trondheim trial with comparable inclusion criteria included 68% of 
their target population (Indredavik et al., 2000). This trial was judged to have good external 
validity (Fjaertoft et al., 2005).  
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The setting for this trial was a dedicated stroke unit in cooperation with the primary health 
care system in three rural municipalities. The organisation of the primary health care system 
may be different in rural communities and urban centres, and consequently our results may 
not be applicable to other settings.  
 
The present trial is judged to have high internal validity. However, this is the first ESD trial 
conducted within a rural setting, and the small sample size makes it difficult to generalise the 
results, hence the trial has low external validity. Final conclusions about the effect of an ESD 
service for patients living in a rural community cannot be drawn before a number of ESD 
trials or a multisite trial is conducted within this setting.  
 
6.5 Comparing the CIMT trial with other studies 
 
To our knowledge seven randomised controlled trials evaluating the effect of six hours’ daily 
CIMT have been published before our trial (Sterr et al., 2002; Suputtitada et al., 2004; Taub et 
al., 1993; Taub et al., 2006; van der Lee et al., 1999; Wittenberg et al., 2003; Wolf et al., 
2006). Our results will be discussed in the light of these seven trials summarised in Table 5. 
Different outcome measures are used in these trials. In Table 5 the results on Wolf Motor 
Function Test and Motor Activity Log are preferably reported if used. In two trials Action 
Research Arm test is reported instead. 
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6.5.1 Setting 
 
Two of the previous trials were conducted in Europe (Sterr et al., 2002; van der Lee et al., 
1999), one in Asia (Suputtitada et al., 2004) and four in the US (Taub et al., 1993; Taub et al., 
2006; Wittenberg et al., 2003; Wolf et al., 2006). There are significant differences between 
the health care system in the US and Norway. This can make comparison between studies 
difficult, but as the intervention is clearly defined it should still be possible to compare the 
results. The majority of the trials have accomplished the supervised treatment at an outpatient 
clinic, with the patients living in their homes, and only one other trial carried out the 
intervention in an in-patient setting (Wittenberg et al., 2003), comparable to our trial. The in-
patient setting was chosen because patients were recruited from the entire Central Norway  
Regional Health Authority, many living a long way from the hospital. An outpatient setting 
would probably have emphasised more functional training during the afternoon with the 
patients living in their own homes. However, the in-patient setting had the advantage of 
encouraging the patients to wear their mitten during the afternoon.  
 
CIMT is conducted as both individual therapy and as group therapy. Our patients were treated 
in groups with up to four patients in line with two other trials (Suputtitada et al., 2004; van der 
Lee et al., 1999). The groups were well staffed with a physiotherapist, an occupational 
therapist and a nurse when needed. This staffing is near to individual therapy and is 
comparable to an individual therapy setting. Based on this we will maintain that our setting is 
comparable to the setting of other CIMT trials. 
 
6.5.2 Study patients 
 
The present trial targeted patients with unilateral impairment of the upper extremity after 
stroke. Our patients had to demonstrate at least 20˚ of active wrist extension and 10˚ of active 
finger extension and weakness or reduced dexterity of the affected hand evaluated by clinical 
assessment. The latter is in contrast to most of the other trials using a maximum score (2.5 or 
2.7 points) on the Motor Activity Log (Wolf et al., 2006; Taub et al., 2006; Wittenberg et al., 
2003) or Action Research Arm test less than 51 points (maximum 57) (van der Lee et al., 
1999; Suputtitada et al., 2004). Initial Motor Activity Log, amount of use, score in our CIMT 
group was ranging from 0.33 – 4.13 indicating that some of our patients had merely minor 
impairments in the affected arm and hand and consequently only minor potential to improve.  
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 Our upper age limit was 80. Although this criterion was only used by two other studies (van 
der Lee et al., 1999; Suputtitada et al., 2004) the mean age in our trial, 62 years in the CIMT 
group and 60 years in the control group, was close to the other CIMT trials listed in Table 5. 
However, this is a fairly young sample compared to the mean age of the total stroke 
population, which is 77.7 years for women and 75.3 years for men (Ellekjaer et al., 1997). Six 
hours of daily CIMT is probably not suitable for the oldest patients, as comorbidity increases 
with age (Wyller, 2007) which may reduce the ability to conduct intensive training. 
 
In the present trial we wanted to include both subacute and chronic patients, ranging from one 
month to eight years after stroke. This is in contrast to all other comparable trials listed in 
Table 5 including only patients with chronic stroke, except the EXCITE trial, including 
patients three to nine months after the stroke (Wolf et al., 2006).  
 
Patients with severe aphasia, neglect, and cognitive impairments are generally excluded from 
CIMT trials and different measures are used for screening of these impairments. According to 
the Mini-Mental State Examination a cut-off between 23/24 (Wolf et al., 2006; Taub et al., 
2006), 21/22 (van der Lee et al., 1999), or 20/21 (Sterr et al., 2002) was used in previous 
trials. In addition different kind of aphasia tests are used (Sterr et al., 2002; van der Lee et al., 
1999; Taub et al., 1993). In our CIMT trial we chose a cut-off between 20/21 on the Mini-
Mental State Examination. We had no aphasia test; however, based on clinical experience, we 
considered that patients with severe aphasia would be excluded according to the chosen cut-
off on the Mini-Mental State Examination while patients with minor aphasia were allowed to 
be included. Patients with neglect were excluded if they deviated more than 2 cm from the 
centre in line bisection. Twelve points or less on Montgomery and Aasberg Depression Rating 
Scale was another exclusion criterion.  
 
In conclusion, it would appear that our patients are comparable in age to most other CIMT 
trials but that they might have reached a higher functional level before inclusion. This higher 
initial functional level may make it more difficult to achieve further significant improvement.  
However, no other trials have included patients as early as we did. Despite these minor 
deviations, our patients are comparable to patients studied in other CIMT trials. 
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6.5.3 The study intervention 
 
Although CIMT is a well described technique there are some differences in the application of 
some of the components of the treatment. Firstly, it seems like the shaping procedure is 
conducted in an even more systematic way in the trials by Taub et al (Taub et al., 2006; Taub 
et al., 1993) than in the present trial,  especially with regard to rigorous recording of increased 
speed, weight and complexity of task performance. Secondly, the restraint on the less affected 
arm is achieved in different ways. A resting hand splint and arm sling ensemble was applied 
in five trials (Sterr et al., 2002; van der Lee et al., 1999; Wittenberg et al., 2003; Taub et al., 
2006; Taub et al., 1993) while a glove or mitten was applied in two trials (Suputtitada et al., 
2004; Wolf et al., 2006). In the present trial we chose to apply a mitten because it was easy 
for the patient to remove for safety and hygienic reasons. The disadvantage was that the 
patients could to some extent use the less affected arm to support the more affected arm when 
struggling with a task. However, these minor differences in performance of the intervention 
are not expected to have any noteworthy impact on the results. 
 
Our control group received standard rehabilitation, ranging from no treatment to a variety of 
occupational and physical therapy in the home or outpatient hospital visits. This was 
equivalent to the control treatment provided by Wolf et al (2006). The control treatment in the 
other trials varied widely in terms of both content and intensity. This great variability in 
control treatments may explain some of the variation in the results of these studies. 
 
In conclusion, our CIMT treatment is comparable to the treatment applied in all other 
comparable studies. However, it seems like the EXCITE trial by Wolf et al (2006) is the most 
comparable trial in terms of the control treatment applied. 
 
6.5.4 Results 
 
The significantly shorter performance time and better functional ability according to our 
primary outcome measure, Wolf Motor Function Test, in the CIMT group compared to the 
control group at post treatment assessment is confirmed by the EXCITE trial (Wolf et al., 
2006). However, the difference did not persist at 6 months follow-up, which is in contrast to 
Wolf et al (2006) who found significant differences between the groups in performance time 
but not in functional ability at all follow-up assessments (4 months, 8 months and 12 months).  
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Our control group showed a significant improvement from baseline to 6 months follow-up. 
The inclusion of patients with subacute stroke may explain some of this improvement. An 
additional explanation is the amount of standard rehabilitation given to the control group. The 
mean (SD) time with physiotherapy and occupational therapy given to the control group 
during the intervention period was 1.7 (1.3) and 0.8 (1.5) hours per week respectively. Both 
groups were free to continue with standard rehabilitation after the intervention period. The 
low dose of standard rehabilitation given over a longer period may have caused some of the 
improvement for the patients in the control group. This somewhat unexpected improvement in 
the control group is also seen in the EXCITE trial including 222 patients (Wolf et al., 2006). 
The low sample size and increased risk of Type II error, i.e. failing to reject the null 
hypothesis when the alternative hypothesis is true (Rosner B, 2000), is another possible 
explanation for no long-term effect revealed in the present trial.  
 
Four trials, with varying degrees of intensive arm training applied in the control group, 
showed conflicting results according to post treatment and follow-up assessment on the 
laboratory measurements (Sterr et al., 2002; Suputtitada et al., 2004; Wittenberg et al., 2003; 
van der Lee et al., 1999). Sterr et al (2002) applied three hours of CIMT in the control group, 
while Wittenberg et al (2003) applied three hours of bimanual upper extremity training. The 
trials found a significant improvement in both groups, but no differences between the groups 
according to the Wolf Motor Function Test. This indicates that less intensive training may 
also be beneficial. Van der Lee et al (1999) and Suputtitada et al (2004) applied six hours of 
bimanual training in the control group, the former showing a significantly greater 
improvement in the CIMT group, which persisted at one year follow-up while the latter 
revealed no short-term effects according to the total Action Research Arm score. These 
somewhat conflicting results may be explained by the correction for baseline differences in 
the former and not in the latter trial and the result suggests that the force used is a significant 
part of CIMT.  
 
The primary aim of CIMT is to increase the use of the more affected arm in activities of daily 
living and the Motor Activity Log is presumed to measure the attainment of this goal. The 
Motor Activity Log is a self-reported measure which demands good cognitive skills. This 
measurement has so far yielded the most convincing results with significant greater amount of 
use of the affected arm in the CIMT group compared to the control group in previous trials 
(Sterr et al., 2002; Taub et al., 2006; Taub et al., 1993; van der Lee et al., 1999; Wittenberg et 
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al., 2003; Wolf et al., 2006). This is in contrast to the present trial, showing only a trend in 
favour of the CIMT group according to the Motor Activity Log on both the amount of use 
scale and the quality of movement scale. Our blinded tester was cautious, trying not to 
influence the patients to exaggerate their scores when completing this form. This may have 
led to underestimation of the actual improvement of the amount of use of the affected arm in 
our patients. Another possible explanation is that the amount of use of the affected arm was 
overestimated in other comparable studies. Although the reliability of 28 out of 30 items on 
the Motor Activity Log is verified by Uswatte et al (2006), we experienced that patients 
wanted to give socially desired answers, and the tester had to be extremely aware of this 
problem. It is a challenge to find appropriate ADL measurements for this intervention, 
because traditional measurements such as the Functional Independent Measure and Barthel 
Index do not register increased participation of the more affected arm. However, goal 
achievement is an clinically important outcome and the use of Goal Attainment Scaling (Hurn 
et al., 2006) should be tested in future CIMT studies. 
 
The Stroke Impact Scale was chosen to measure self-perceived health at 6 months follow-up, 
but the analysis did not reveal any differences between the groups in any domain within this 
scale. This result supports the lack of long-term effect found in the present trial. This is in 
contrast to the EXCITE trial, which showed a significant difference between the two groups 
according to self-perceived hand function at both four and twelve months follow-up (Wolf et 
al., 2006). No other previous studies have reported on self-perceived health, although it is an 
important aspect of recovery after stroke, and further studies should incorporate the evaluation 
of this aspect. 
 
In conclusion, our CIMT trial is comparable to most other CIMT trials according to setting, 
study patients and the CIMT programme, supporting the validity of our results. However, our 
control treatment is only comparable to the control treatment applied in the EXCITE trial, and 
the lack of long-term effect may be explained by the small sample size in our trial. The 
significant improvement in our control group at six months follow-up and the results from 
other CIMT trials indicates that less intensive training over a longer time period may also be 
beneficial and should be tested in future studies to find the optimal amount and duration of 
this treatment. 
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6.6. Internal validity of the CIMT trial 
 
6.6.1 Selection bias 
 
The randomisation procedure in the present trial was equivalent to the procedure used in the 
ESD trial, and has probably not introduced any selection bias. However, we knew from the 
planning of the trial that our sample size would be relatively small with increased risk of 
uneven distribution of prognostic baseline variables, i.e. time from onset of stroke. 
 
Patients in the subacute phase after stroke have an exponential recovery curve compared to 
patients in the chronic phase (Jorgensen et al., 1995b). As our patients ranged from one month 
to eight years after onset of symptoms, an uneven distribution of this variable may bias the 
results. The baseline variables showed no significant differences between the groups, but 
some imbalance was observed. The analysis of covariance (ANCOVA) is the preferable 
statistical method in this situation (Vickers & Altman, 2001). Months since stroke was used as 
a covariate in these analysis but revealed no significant changes, indicating that the variable is 
equally distributed or does not have any major impact on the outcome. However, further 
studies should include a more homogenous group of patients according to time from onset. 
There are too few eligible patients with acute stroke admitted to any single hospital in our 
country. A multi-site trial will therefore be necessary to include sufficient subacute patients 
within a reasonable time limit, in further CIMT studies conducted within the Norwegian 
health care system. 
 
Other potential prognostic variables include age, gender and side affected. All of these 
variables were entered, one by one, as covariates in a second-level analysis. However, none of 
them influenced the outcome.  
 
The randomisation to a CIMT group or a control group was according to the ratio 3:2 
respectively. This ratio was chosen because we needed as many patients as possible in the 
CIMT group to assess feasibility. In addition, not much statistical power is lost by moderate 
deviations from equal groups (1:1 randomisation ratio). For example, if the effect size is 1.2, 
(mean difference divided by standard deviation), a 0.05 level two-sample t-test has power 
88.7% or 87.5% with 15:15 or 18:12 allocation, respectively. 
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6.6.2 Performance bias  
 
All patients randomised to the CIMT group were treated according to the CIMT intervention, 
and all the patients randomised to the control group received standard rehabilitation. 
However, some of the patients in the control group were in-patients at the rehabilitation clinic 
where the CIMT intervention took place during the trial. Although CIMT patients and control 
patients were admitted to different wards, we cannot preclude that some control patients have 
been inspired to increase their amount of individual training, which also was confirmed by the 
staff at the rehabilitation clinic. However, this bias goes in disfavour to the CIMT group and 
may explain some of the improvement in the control group.  
 
As both groups were free to continue standard rehabilitation after the intervention period it is 
reasonable to anticipate that this treatment is equally distributed between the two groups. 
 
6.6.3 Detection bias 
 
The person who performed all the assessments in the present trial was blinded to patient 
assignment. It was impossible to blind the patients to their assignment, and therefore this was 
a single blinded trial. 
 
Our primary outcome, Wolf Motor Function Test, is one of the most commonly used 
measurements in previous CIMT trials (Sterr et al., 2002; Taub et al., 2006; Taub et al., 1993; 
Wittenberg et al., 2003; Wolf et al., 2006). The test is recorded on video tape and the 
performance time and functional ability is rated from the video recordings. The reliability and 
validity of the instrument is stated in Table 3. To ascertain the reliability in the present trial 
two blinded assessors rated the video tapes. Tasks with discrepancy in the rating were 
discussed by the two raters before they came to agreement. This procedure should minimise 
the chance of detection bias. 
 
CIMT is meant to result in enhanced quantity and quality of participation of the affected arm 
in activities of daily living and the Motor Activity Log was developed to measure this 
improvement (Taub et al., 1993). The Motor Activity Log is a structured interview to assess 
the use of the paretic arm and hand during given activities of daily living. The reliability is 
stated by Uswatte et al (2006). However, it is not recommended to use the measurement as a 
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primary outcome because the improvement during an intervention period was only weakly 
correlated to improvement with a performance based measurement (Action Research Arm 
test) and the longitudinal construct validity is supposed to be weak (van der Lee et al., 2004). 
In our trial the Motor Activity Log was used as a secondary measurement and it did not 
confirm the improvement revealed by the Wolf Motor Function Test.  
 
6.6.4 Attrition bias 
 
No patients were excluded from the trial after being allocated to the treatment groups, and no 
patients died or dropped out during follow-up. This excludes the possibility for any attrition 
bias in this trial. 
 
In conclusion, the small sample size may have increased the risk of selection bias in our 
CIMT trial. The possibility of performance bias may have influenced the results in disfavour 
of the CIMT group. However, there is no evidence for detection bias or attrition bias in this 
trial, and our CIMT trial is judged to have high internal validity. 
 
6.7 External validity of the CIMT trial 
 
The proportion of eligible patients has been estimated by Taub et al (1993) to be 
approximately 20% to 25% of the stroke population (Taub et al., 1993), which may be a very 
optimistic estimate. So far, the EXCITE trial is the only CIMT trial reporting the number of 
patients screened for inclusion and the proportion of patients included in the trial. In this trial 
only 6% of the patients screened for inclusion were eligible (Wolf et al., 2006). The inclusion 
and exclusion criteria in the present trial were very similar to those applied in the EXICITE 
trial, and consequently a highly selected group of stroke patients was included. It follows that 
one should be careful to apply the results of this trial to other stroke subgroups. 
 
The setting of the present trial was an in-patient rehabilitation clinic. The use of the constraint 
on the unaffected arm during 90 % of waking hours may be different for the in-patient 
compared to the outpatient setting. The in-patients have the advantage of the presence of staff 
to encourage the use of the mitten in demanding activities of daily living, and the outpatients 
having the advantage of practicing in more realistic environments in their homes. However, 
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we will argue that the advantages or disadvantages of an in-patient setting are not a major 
problem to the external validity and our CIMT treatment can probably be applied to an 
outpatient setting as well.  
 
The improved short-term effect of CIMT compared to standard treatment shown in our CIMT 
trial is verified by the EXCITE trial. Based on this and the high internal validity of the present 
trial, the results could be applied to a highly selected group of stroke patients. However, the 
small sample size implies that the results should be interpreted with caution.  
 
Finally, CIMT is a resource demanding technique, and the cost-effectiveness of the treatment 
should therefore be a focus in future research. 
 
6.8 Comparing the fMRI study with other studies 
 
In a literature search on PubMed reviewing only English-language papers, we identified 14 
comparable longitudinal studies, assessing the change in brain activation after stroke using 
fMRI or PET (Nelles et al., 1999; Marshall et al., 2000; Calautti et al., 2001; Calautti et al., 
2003; Small et al., 2002; Feydy et al., 2002; Ward et al., 2003; Jang et al., 2003; Loubinoux et 
al., 2003; Loubinoux et al., 2007; Tombari et al., 2004; Carey et al., 2005; Jaillard et al., 2005; 
Thiel et al., 2007). These studies vary widely according to location of ischaemic lesion, time 
since stroke, and age of the patients included in the respective studies. They also vary with 
regard to the applied task paradigms, clinical outcome measures and outcome of image 
analysis, such as laterality indices, coordinates of activated maxima, displacement of 
coordinates, volume of activated voxels, and so on. However, our fMRI study will be 
discussed within this variable framework.  
  
6.8.1 Study patients 
 
The age of the patients included in the present study ranged from 62 to 75 (mean; 67), while 
the age of patients included in the other comparable studies ranged from 29 to 75, showing 
that our patients are in the upper limit of this range. Four studies included patients with mixed 
infarctions (cortical and sub-cortical) in both hemispheres (Small et al., 2002; Feydy et al., 
2002; Ward et al., 2003; Jang et al., 2003; Carey et al., 2005) comparable to our patients. One 
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study included only cortical infarctions in the right hemisphere (Jaillard et al., 2005), while 
the nine remaining studies included sub-cortical infarctions in both hemispheres (Nelles et al., 
1999; Marshall et al., 2000; Calautti et al., 2001; Calautti et al., 2003; Loubinoux et al., 2003; 
Loubinoux et al., 2007; Tombari et al., 2004; Thiel et al., 2007). The initial functional level 
assessed on the Barthel Index in our study ranged from 55 to 100 points. The functional level 
in the other comparable studies was assessed with a variety of outcome measures, which 
makes a direct comparison difficult. However, five studies have used the Barthel Index, 
showing an initial functional level ranging from 35 points to 100 points in four of the studies 
(Calautti et al., 2001; Ward et al., 2003; Loubinoux et al., 2003; Thiel et al., 2007), which is 
relatively similar to the functional level in our patients, while one study reported an initial 
functional level ranging from 15 points to 100 points (Tombari et al., 2004).  
 
Although there is significant variability in the patient characteristics in our study and in 
previously published longitudinal fMRI studies it can be said in summary that patients 
included in the present study are fairly comparable to patients included in other fMRI studies 
in terms of their age, functional level, and location of infarctions. However, patients who are 
eligible for fMRI studies make up a small and highly selected group of patients, who are 
younger and less disabled than the general stroke population. 
 
6.8.2 Study intervention 
 
All our patients received evidence-based stroke unit treatment with emphasis on early 
mobilisation and task-oriented physiotherapy (Indredavik et al., 1991). In addition, early 
supported discharge coordinated by a multidisciplinary team was given during the further 
follow-up care (Indredavik et al., 2000; Fjaertoft et al., 2003). The treatment given to the 
stroke patients included in the other comparable studies is not well described. We suggest the 
high quality treatment given to our patients may be a distinctive characteristic compared to 
other fMRI studies. 
 
6.8.3 Results  
 
The main result of the present study was a statistically significant improvement in functional 
recovery according to all the applied functional outcome measures, despite fairly similar 
activation maps in the acute and chronic phases. However, in a comparison of the two phases, 
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three mechanisms were identified as central to successful recovery. These are (1) changes in 
activation patterns from the acute to the chronic phases comparable to that described in motor 
learning studies, (2) re-establishment of activation within the primarily lateralised motor 
network, and (3) recruitment of bilateral somatosensory association areas and contralesional 
secondary somatosensory cortex (SII).  
 
Laterality indices increased significantly in primary sensorimotor cortex (MISI) and 
cerebellum from the acute to the chronic phases. This finding is confirmed by previous studies 
reporting increasingly higher laterality index as recovery takes place (Feydy et al., 2002; 
Marshall et al., 2000). However, when taking all hemispheric cortical ROIs into account, the 
laterality index was not significantly different in the two phases. This finding suggests the 
reemergence of the lateralised MISI and cerebellar activation combined with extensive 
bilateral somatosensory association and contralesional SII recruitment. These regions are also 
more active in the chronic compared to the acute phase. Increased activation of contralesional 
SII has so far been reported to be associated with good recovery of motor function after stroke 
in one other longitudinal neuroimaging study (Thiel et al., 2007). Two recent cross sectional 
studies also emphasise the importance of bilateral and contralesional recources for successful 
recovery after stroke (Gerloff et al., 2006; Schaechter & Perdue, 2008). SII in particular, but 
also somatosensory association areas, have neurons with bilateral receptive fields, connected 
through transcallosal projections and possibly via thalamic fibres (Iwamura et al., 2001). 
These regions project massively to both primary and secondary motor areas, and give rise to 
sub-cortical and corticospinal projections. It is hypothesised that in patients who have made 
good recovery after hemiparetic stroke, the ipsilesional MI may rely more heavily on the 
contralesional MI to control spatiotemporal aspects of affected hand movement (Schaechter & 
Perdue, 2008). Increased activity in contralesional MI was only associated with good recovery 
of key grip strength in the present study. However, our results indicate that functional 
recovery after stroke appears to be linked to plasticity in somatosensory structures in the 
contralesional hemisphere. 
 
The increased bilateral activation of the thalami from the acute to the chronic phases suggests 
that this sub-cortical pathway is of major importance for integration of sensory input and 
motor action in successful motor recovery. Furthermore, afferents from contralesional 
somatosensory regions may directly or indirectly influence movement via ipsilateral 
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corticospinal projections, but the importance of this system is undetermined (Jankowska & 
Edgley, 2006).  
 
By using a range of outcome measures, each reflecting a different aspect of recovery, a more 
comprehensive understanding of recovery is possible (Duncan et al., 2000). The results from 
the covariate analysis in the present study strengthen the importance of contralesional 
somatosensory association areas and SII activation in regaining the ability to perform more 
complex motor tasks demanding the coordinate activity and dexterity of the entire hand as 
demonstrated by the positive correlation between UL-MAS and NHPT. Transversal grip 
strength was also associated with increased contralesional SII activation in addition to 
increased ipsilesional primary somatosensory activation. The key-grip strength test (KGS), on 
the other hand, correlated with bilateral hand MI activation with ipsilesional dominance. MI is 
the only region projecting directly to the motor neurons, and the present result points to 
preservation of the ipsilesional MI as the major contributor to force in this group of patients 
with good recovery. Other studies analysing the association with functional recovery have 
used a variety of different functional outcome measures (Nelles et al., 1999; Calautti et al., 
2001; Ward et al., 2003; Loubinoux et al., 2003) and summary scores (Feydy et al., 2002; 
Small et al., 2002) which makes comparison difficult. 
 
Although, Krakauer (2006) has proposed that motor learning mechanisms is operative during 
spontaneous recovery and interact with rehabilitative training, no other longitudinal studies 
have, to our knowledge, investigated motor network changes after stroke in relation to motor 
learning. Our results will in the next paragraph be discussed in the light of these processes.  
 
In the acute phase compared to the chronic phase, ipsilesional angular gyrus and insula and 
bilateral putamen/globus pallidi plus contralesional cerebellum were significantly more 
activated. In the chronic phase compared to the acute phase, there was increased activation of 
ipsilesional hand region of MISI, bilateral somatosensory association cortex, contralesional 
SII plus contralesional cerebellum and bilateral thalami. These activation patterns are 
comparable to neuroimaging studies of neuronal network changes during the course of motor 
skill learning (Doyon et al., 2003). In the early learning stage there is extended bilateral 
cerebellar and striatal activation that declines with practice to be replaced by a predominantly 
sensorimotor cortex network with varying contributions from striatum and/or cerebellum 
depending on experimental set-up (Doyon et al., 2003; Flament et al., 1996). The increased 
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cerebellar activation in the early phase of motor skill learning is considered to reflect 
unconscious monitoring and correction of task performance (Imamizu et al., 2000; Flament et 
al., 1996). This was also found in the present study. In addition there was evidence for greater 
conscious awareness of task performance indicated by the increased activation of ipsilesional 
angular gyrus (Farrer et al., 2008) in the acute phase.  
 
In conclusion, the present study demonstrates that patients with spared ipsilesional MISI  
treated with a task-oriented approach have brain activation changes comparable to changes 
observed in motor skill learning. This result supports the postulation about motor learning 
mechanisms being operative during spontaneous stroke recovery, and that these interact with 
rehabilitative training (Krakauer, 2006). The increased contribution of bilateral somatosensory 
association and contralesional SII associated with successful motor recovery emphasises the 
significance of bi- and contralesional resources in recovery after stroke (Thiel et al., 2007; 
Gerloff et al., 2006; Schaechter & Perdue, 2008).  
 
6.9 Internal validity of the fMRI study 
 
6.9.1 Detection bias 
 
The person who performed the analysis of the images was blinded to the functional outcome 
of the patients reducing the risk of detection bias. 
 
Our study was based on the assumption that the baseline activation and the haemodynamic 
response are the same in both the acute and chronic phases. However, the validity of the 
relationship between motor performance, the neuronal activation and BOLD response is 
discussed. Kranik et al (2005) found a heterogeneity in the cerebrovascular reactivity and 
suggested that this heterogeneity could be a methodological issue in functional imaging 
studies using task-related BOLD signal in poststroke patients (Krainik et al., 2005). Binkofski 
and Seitz (2004) found a presence of perilesional activation during motor performance in the 
subacute stage after the stroke and the transient lack of this activation during the early chronic 
stage despite the clinical improvement of function in the affected hand. The BOLD response 
reoccurred in the chronic stage (Binkofski & Seitz, 2004). Based on this we cannot exclude 
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the possibility that some of the changes or lack of changes from the acute to the chronic 
phases are caused by these methodological uncertainties.  
 
The choice of movement paradigm used in fMRI studies is also discussed. It is observed that 
cerebral activation covariates with movement rate in healthy subjects. Increased tapping rate 
results in increased BOLD signal intensity as well as the volume of activation in the 
contralateral primary motor cortex (Khushu et al., 2001). However, this linear relationship 
does not apply to all motor areas (i.e. cerebellum) during the finger tapping (Riecker et al., 
2003). A comparison of brain activation in patients requires that they all perform an 
equivalent motor task, but it is almost impossible to ask a group of stroke patients with 
different functional levels to perform a task in an identical manner and to do it exactly the 
same way in both the acute and chronic phases. As patients recover, and function improves, 
the task will be performed in a more skilled manner and the task is not the same any longer. 
Our SP task was chosen to ensure that all patients spent about the same effort to conduct the 
task. In addition we chose to use movement rate as a regressor in some of the analysis, to 
normalise for the difference in movement rate between subjects and to adjust for the change in 
movement rate within each subject from the acute to the chronic phases. This analysis showed 
only minor deviation from the analysis without movement rate as a regressor. 
  
In conclusion, BOLD fMRI is considered to have good internal validity in healthy subjects 
(Stoeckel et al., 2007). However, there are some concerns about the internal validity for 
patients with cerebrovascular diseases. 
 
6.10 External validity of the fMRI study 
 
Only 4% of the stroke patients screened for inclusion were eligible to participate. Although no 
stroke type was actively excluded, the strict inclusion criteria resulted in a highly selected 
sample. None of the patients had language or other cognitive deficits, because they had to 
understand the experimental instructions. Furthermore, all patients had to regain the ability to 
actively move their affected fingers within four days post-stroke. In addition, the BOLD 
response might be weaker in old age (D'Esposito et al., 2003) and we decided to exclude those 
patients older than 75 years of age. As a result, our sample consisted of a highly selected 
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group of stroke patients, comprising fairly young patients with small infarction not 
encompassing the motor cortex. 
 
A variety of different motor-task paradigms are used in the comparable fMRI studies, most of 
them at a fixed rate. Our simple SP task does not measure motor skill relearning directly but 
indirectly through the association to motor recovery and relearning of motor skills, assessed 
with our outcome measures. In future studies different functional tasks should be tested out in 
fMRI studies to get a more direct measure of the learning process. 
 
In addition to the concerns about the internal validity, the small and highly selected sample 
size implies that our results should be interpreted with caution. Hence, the external validity is 
weak and the study should mainly be regarded as hypothesis-generating work which may 
enhance our understanding of underlying mechanisms in recovery from stroke, and help to 
suggest directions for further research in this field. The question of whether task-oriented 
training based on motor learning principles facilitates brain activation patterns comparable to 
changes in motor learning studies should be tested in a larger study. The significance of 
bilateral somatosensory association area and contralesional SII activation for successful motor 
recovery should also be further investigated. 
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7 Conclusions 
 
- An ESD service for stroke patients living in a rural community did not appear to have 
beneficial effect on death or dependency, balance or walking speed in the short or long 
term, but might give a transient reduction in social isolation. However, when analysing 
all patients who completed all assessments the results revealed a non-significant trend 
toward greater improvement on the Berg Balance Scale in the ESD group, indicating a 
possible beneficial effect on balance from early rehabilitation in the patient’s home. 
 
- A strong association was identified between initial severe leg paresis, but not with 
initial moderate leg paresis, and reduced balance one year after the stroke. There was 
also a strong association between initial inability to walk and reduced balance one year 
after the stroke. 
 
- CIMT conducted as group therapy was feasible, and it improved motor function in the 
affected arm in the short term for a selected group of patients after stroke. It is unclear 
whether CIMT is superior to standard rehabilitation in the long term as no long-term 
effect was revealed. 
 
- Functional MRI analysis of a highly selected group of stroke patients treated with 
task-oriented training revealed motor network changes comparable to changes 
described in motor skill learning studies.  
 
- The recruitment of bilateral somatosensory association areas and contralesional 
secondary somatosensory area seems to be of significance for successful motor skill 
relearning after stroke.  
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8 Suggestions for future research 
 
- There is a challenge for future research in stroke rehabilitation to develop treatment 
protocols that can be applied in multi-site trials. A multi-site design should be applied 
for studies of both ESD services for patients living in rural communities and for 
studies of CIMT. Although one multi-site CIMT trial has already been conducted in 
the US, it would be desirable for this trial to be replicated within a European setting.   
  
- It appears that both task-specific and intensive treatment is beneficial after stroke. 
Future research should focus on detecting the appropriate intensity and amount of 
training to achieve the highest possible functional level. Cost-effectiveness analysis 
should be performed within this setting. 
 
- Future research should also focus on deriving more understanding about significant 
changes within the motor network associated with successful improvement of motor 
skills, and on investigating how different interventions, such as CIMT, affect  brain 
plasticity.   
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”…, and a programme of functional exercises in the patient’s home or in an outpatient clinic, 
to improve both balance and walking speed after stroke (6-8).”  
 
 Should be replaced by;  
” …., and a programme of functional exercises conducted  in the patient’s home or in an 
outpatient clinic, improved both balance and walking speed after stroke (6-8).” 
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DOES AN EXTENDED STROKE UNIT SERVICE WITH EARLY SUPPORTED
DISCHARGE HAVE ANY EFFECT ON BALANCE OR WALKING SPEED?
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Objective: To evaluate the effect of an extended stroke unit
service with early supported discharge on balance and walking
speed, and to explore the association between initial leg
paresis, initial movement ability and balance one year after
stroke.
Design: A randomized controlled trial comparing early
supported discharge with ordinary stroke unit service.
Patients: A total of 62 eligible patients after stroke.
Methods: The outcome measures were Berg Balance Scale
and walking speed at 1, 6, 26 and 52 weeks after stroke.
Results: We found no significant differences between the
2 groups during follow-up. There was a significant improve-
ment on Berg Balance Scale (p/0.013) and walking speed
(p/0.022) in the early supported discharge group, but not in
the ordinary service group, from 1 to 6 weeks’ follow-up. All
patients with initial severe leg paresis suffered from poor
balance one year after the stroke. The odds ratio for poor
balance was 42.1 (95% confidence interval; 3.5513.9) among
patients with no initial walking ability.
Conclusion: These results do not conclusively indicate that
early supported discharge has an effect on balance. A strong
association was found between initial severe leg paresis, initial
inability to walk and poor balance after one year.
Key words: Stroke, posture, gait, rehabilitation.
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INTRODUCTION
Effective stroke unit care with early mobilization improves
functional outcome after stroke (1, 2), however, increased risk
of falling is a major problem among patients after stroke (3),
and impaired balance is one of the main reasons for falling
(4). It is beneficial to provide further intensive exercise
therapy in the subacute and chronic phase (5), and a
programme of functional exercises in the patient’s home or
in an outpatient clinic, to improve both balance and walking
speed after stroke (68).
Patients after stroke conventionally undergo a substantial
part of their rehabilitation in hospital or rehabilitation clinics. A
new kind of service has been developed during the last decade
that offers patients early supported discharge (ESD), namely
early discharge from hospital with rehabilitation at home. This
service seems to reduce long-term dependency (9).
ESD is a composite intervention and comparing the results
among various studies is difficult because ESD is conducted in
different ways. Early discharge coordinated by a multidisciplin-
ary team seems to be an important factor and the early exercise
therapy in the patient’s home is another factor that could be
beneficial. This early exercise therapy in the patient’s home
could be defined as task-specific because it consists of
functional tasks conducted in a functional setting. Task-specific
training is recommended in further research to improve balance
and functional outcome after a stroke (10, 11). Previous ESD
trials have shown good functional outcome after stroke (9, 12,
13). Improved balance and walking speed may contribute to this
result. However, it is still unknown whether ESD is beneficial to
balance or walking speed.
Early prediction of functional outcome is another important
topic in stroke management, and there is growing interest in
conducting longitudinal studies to study the relationship
between impairments and disability (3, 14, 15). Kollen et al.
(15) claim that initial standing balance is more important than
improvement in leg strength to achieve improvement in walking
ability, while Jørgensen et al. (14) found a strong relationship
between leg paresis and walking function. However, more
knowledge about the relationship between specific body func-
tions, such as initial leg paresis or movement ability, and
activities, such as improvement in balance during mobility,
would be useful in selecting optimal treatment strategies after
stroke.
Two ESD trials have been conducted at the Stroke Unit at the
University Hospital of Trondheim. The first trial showed
reduced death and dependency for patients living in the city
of Trondheim (12, 16) and the second trial showed no beneficial
effect on functional outcome for patients living in a rural
community (17). This study is based upon secondary outcomes
from the trial evaluating early supported discharge for patients
living in a rural community (17).
The aims of this study were to evaluate the effect of an extended
stroke unit service (extended service) with ESD on balance and
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walking speed and to explore initial factors associated with
balance one year after treatment in an acute stroke unit.
SUBJECTS AND METHODS
Subjects
Patients from 3 municipalities surrounding the city of Trondheim, who
had been admitted to the Stroke Unit at Trondheim University Hospital,
were screened for inclusion in the trial. Inclusion criteria were: diagnosis
of an acute stroke according to the World Health Organization
definition of stroke (18); Scandinavian Stroke Scale (SSS) (19) score
greater than 2 points and less than 58 points; living at home before the
stroke; inclusion within 72 hours after admission to the stroke unit and
within 7 days after the onset of symptoms; able and willing to provide
informed consent.
Research design
In the present study a randomized controlled design was used. Patients
fulfilling the inclusion criteria were included and block randomized in
blocks of 4, 6 or 8 patients, to either an ordinary stroke unit service
(ordinary service) or the newly constructed extended service. The order
of the blocks was randomly chosen. Sealed opaque envelopes were used
for randomization and the procedure was carried out by an external
office.
During the acute phase (the first 12 weeks) both groups received
well-documented stroke unit care with focus on early mobilization
combined with a standardized medical programme (20). The follow-up
care for the ordinary service group is combined with further inpatient
rehabilitation when more long-term rehabilitation is necessary or a
follow-up programme organized by the primary healthcare system.
The extended service consisted of stroke unit treatment combined with
a home-based programme of follow-up care co-ordinated by a mobile
stroke team that offers early supported discharge and works in close co-
operation with the primary healthcare system during the first 4 weeks
after discharge. In contrast to the ordinary service, the intervention
placed emphasis on early and intensive task-specific exercise therapy in
the patients’ home.
An independent and blinded assessor specially trained in the use of all
the outcome measures performed all the assessments.
The Regional Committee on Medical Research Ethics approved the
study protocol.
Evaluation
Baseline characteristics were recorded before randomization. All
patients were followed-up at 1, 6, 26 and 52 weeks after onset of stroke.
The Berg Balance Scale (BBS) maximum score of 56 was used to
measure balance (21, 22). On the multiple regression analysis BBS was
dichotomized into good balance (BBS ]/45) versus poor balance and
increased risk of falling (BBSB/45) (22).
Walking speed was clocked across a 5 m length. The distance was
walked twice at maximal walking speed. The means of the 2 trials were
used as a test parameter representing the fast speed condition.
Motor function of the leg and the movement ability was assessed by
use of the subscores from the SSS (19). The original leg score is graded
in 5 categories: paralysis (0 point); can move, but not against gravity (2
points); raises leg with flexion in knee (4 points); raises leg straight but
with reduced strength (5 points); and raises leg with normal strength (6
points). This item was categorized into 3 categories; severe paresis (02
points); moderate paresis (45 points) and no paresis (6 points). The
originally movement score is also graded in 5 categories; confined to
one’s bed or wheelchair (0 point); sits without support (3 points); walks
with support (6 points); walks with walking aid (9 points); walks 5 m
without walking aid or support (12 points). This item was categorized
into the following 3 categories; no walking ability (03 points), walks
with support (69 points) and independent walking ability (12 points).
Statistical analysis
Baseline characteristics were compared using Mann-Whitney U test
(ordinal data), t -test for independent samples (ratio data), or x2
tests (nominal data). Outcomes between the 2 groups at 1 week, 6
weeks, 26 weeks and 52 weeks’ follow-up were compared using
Mann-Whitney U test (ordinal data) and t -test for independent samples
(ratio data).
Change within groups analysis were performed on those patients who
had completed all assessments from 1 to 6 weeks, 1 to 26 weeks and 1 to
52 weeks by using Wilcoxon signed rank test on BBS and paired t- test
on walking speed.
Differences in change between groups were analysed by Mann-
Whitney U test on the BBS and by Student’s t -test on walking speed.
The change was calculated as the difference between the 6 week test
minus the 1 week test, the 26 week test minus the 1 week test and the 52
week test minus the 1 week test.
Multiple logistic regression was used to analyse the association
between initial leg paresis and initial movement ability as independent
variables, and the dichotomized BBS score 52 weeks after stroke as the
dependent variable, allowing adjustments for potential confounders such
as age, sex, treatment group and number of days from onset of
symptoms to hospital admission (23).
All the analysis was performed in the statistical programme of SPSS
13.0 for Windows and a p -value less than 0.05 was considered
significant.
RESULTS
Figure 1 shows the flow of patients through the study and the
reasons for exclusion and drop-out according to BBS. In all, 89
patients were screened for inclusion between 1 June 1999 and 15
June 2001. A total of 62 patients were included in the study and
31 patients were randomly allocated to the extended service
group and 31 to the ordinary service group. In the ordinary
service group there were 2 partial drops out at 1 week follow-up.
At 6 weeks’ follow-up, 1 of the patients who were lost to follow-
up because of illness withdrew from the study and another
patient died.
There were no significant differences between the 2 groups for
any of the baseline characteristics (Table I).
Table II shows a significant difference in fast walking speed
(p/0.043) and a trend toward better BBS score (p/0.144) in
the ordinary stroke unit service group at 1 week follow-up.
There were no significant differences in BBS score or walking
speed between the 2 groups at any other time during follow-up.
Changes within the extended service group (Table III)
showed a significant increase in the BBS score from 1 to 6
weeks (p/0.013) and an almost significant increase in BBS
score from 1 to 26 weeks (p/0.051). In addition, there was
a significant increase in walking speed from 1 to 6 weeks
(p/0.022), from 1 to 26 weeks (p/0.044) and from 1 to 52
weeks (p/0.028). There were no significant changes on BBS or
walking speed at any time in the ordinary service group.
The differences in change between the 2 groups showed a trend
toward greater improvement in the extended service group
compared with the ordinary service group from 1 week follow-
up to 6 weeks’ follow-up (p/0.065) and from 1 week follow-up to
26 weeks’ follow-up (p/0.142) on the BBS, but no differences in
change between the 2 groups on fast walking speed.
Visual analysis of Figs. 2 and 3 show an initial improvement
and a later decline on both BBS and fast walking speed.
In our study 36.9% of patients with no leg paresis, 48.4% of
patients with moderate paresis and 100% of patients with severe
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leg paresis showed poor balance after one year. According to
the movement item, 20.0% of patients with initial independent
walking ability, 66.7% of patients able to walk with support and
90.9% of patients with no walking ability showed poor balance.
Table IV shows the calculated odds ratio (OR) for poor balance
among patients with initial leg paresis and reduced movement
ability. Adjustment for potential confounders did not materially
change the results, although the OR for poor balance became
less significant among patients with initial leg paresis and more
significant among stroke patients with reduced initial walking
ability.
DISCUSSION
This study shows no significant differences between the
extended service group and the ordinary service group on
BBS or walking speed at any phase in the treatment. However,
the extended service group had a greater improvement on both
BBS and fast walking speed than the ordinary service group.
The study also shows a strong association between initial severe
leg paresis, initial inability to walk and poor balance.
The strength of this study is the randomized controlled design
with a blinded assessor. In addition the study population is an
unselected population. As shown in Fig. 1 70% of the patients
admitted to the stroke unit met the criteria for inclusion in the
trial. All the included patients received evidence-based stroke
unit treatment according to the ‘‘gold standard’’ (20) and any
improvement would have been in addition to the effect of this
acute treatment.
There were few inhabitants in the 3 rural municipalities, and
consequently a low number of people suffering from stroke. This
was the principally reason for the small sample size. The small
sample size and the low statistical power according to the
primary outcome is the most important weakness of the present
study (17). This leads to an increased risk of uneven distribution
of potential confounders.
There is no data on BBS or walking speed at baseline, though
at 1 week follow-up there was a significantly faster walking
Patients living in the community of Malvik, Melhus and Klæbu with
acute stroke admitted to the Stroke Unit (n = 89)
Randomized
n = 62
Not randomized (n = 27)
*5 SSS score = 2
*3 SSS score > 57
*2 onset of symptoms > 7 days before inclusion
*3 already included in the trial
*5 admitted from institutional care
*2 no informed consent
*7 missed for inclusion because of holiday or other
reasons
ESUS
n = 31
OSUS
n = 31
6 weeks' follow-up
*2 died within 6 weeks
n = 29
6 weeks' follow-up
*1 died within 6 weeks
*1 withdraw from the study within 6 weeks
n = 29
26 weeks' follow-up
*8 died within 26 weeks
n = 23
26 weeks' follow-up
*1 died within 26 weeks
*2 withdraw from the study within 26 weeks
n = 28
52 weeks' follow-up
*8 died within 52 weeks
n = 23
52 weeks' follow-up
*4 died within 52 weeks
*2 withdraw from the study within 52 weeks
*2 lost to follow up because of illness within 52 weeks
n = 23
1 week follow-up
n = 31
1 week follow-up
*1missed for follow up within 1 week
*2 lost to follow up because of illness within 1 week
n = 28
Fig. 1. Flow chart of patients randomized and followed-up with Berg Balance Scale. ESUS/extended stroke unit service; OSUS/ordinary
stroke unit service; SSS/Scandinavian Stroke Scale.
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speed and a trend toward higher BBS score in the ordinary
service group. The intervention cannot explain this difference
because the patients were still in the stroke unit at this time and
the main intervention started at discharge from the stroke unit.
The small sample size and a not completely successful
randomization have to account for this difference. In addition
3 patients were lost to follow-up in the ordinary service group at
1 week follow-up and may have caused additional uneven
distribution. We assume that our analysis comparing groups at
6, 26 and 52 weeks may have been influenced by the initial
difference between the 2 groups.
The BBS is measuring balance according to 14 functional tasks.
Most of the tasks measure balance during sitting or standing
position, and it will be a ceiling effect for patients with very mild
stroke and only minor reduction in balance. However, walking
speed will not suffer from this ceiling effect as the mean fast
walking speed among patients in both groups were much slower
than the usual fast walking speed among people at their age (24).
The cut-off on BBS between 44 and 45 points with an
increased risk of falling for those with a BBS less than 45 points
has been well documented (22), although Harries et al. (25)
recommend clinicians to be cautious when using BBS to
determine fall risk among patients with chronic stroke. The
categorization of the leg and movement items on SSS is done in
different ways in the literature. Jorgensen et al. (3) chose to
dichotomize the leg item, while Jorgensen et al. (14) kept all 5
categories. There is a wide range of paresis, from total paralysis
to a small reduction in strength. It is not likely that moderate
paresis would be the same predictor as severe paresis and the
categorization into 3 categories; no paresis, moderate paresis,
and severe paresis appears to be clinically meaningful. Our
results indicate different associations for these categories with
severe leg paresis compared with those with moderate leg
paresis.
Table I. Baseline characteristics of patients allocated to extended
stroke unit service (ESUS) and ordinary stroke unit service (OSUS)
ESUS
(n/31)
OSUS
(n/31)
Age (years), mean/median 76.9/77.0 76.3/76.0
Sex, number (%) male 16 (51.6) 17 (54.8)
Living alone number (%) 11(35.5) 15 (48.4)
Diagnosis number (%)
Non-embolic infarction 18 (58.1) 20 (64.5)
Embolic infarction 5 (16.1) 8 (25.8)
Haemorrhage 7 (22.6) 3 (9.7)
Transient ischemic attack 1 (3.2) 0 (0.0)
Medical history, number (%)
Transient ischemic attack 6 (19.4) 2 (6.5)
Stroke 2 (6.5) 1 (3.2)
Myocardial infarction 5 (16.1) 7 (22.6)
Atrial fibrillation 3 (9.7) 8 (25.8)
Hypertension 3 (9.7) 10 (32.3)
Diabetes 1 (3.2) 5 (16.1)
Functional state
Scandinavian Stroke Scale,
mean/median 45.4/46.0 41.5/46.0
Barthel Index, mean/median 57.7/55.0 54.0/55.0
Rankin Scale, mean/median 3.7/4.0 3.5/4.0
Table II. Differences between groups on Berg Balance Scale and fast walking speed assessed at 16, 26 and 52 weeks after stroke
ESUS OSUS p -value
1 week post-stroke
Berg Balance Scale (n/31) (n/28)
Mean (SD) 28.6 (21.4) 35.4 (21.4)
Median (IQR)1 32.0 (4.050.0) 43.5 (18.554.8) 0.144
Fast walking speed (m/s) (n/22) (n/22)
Mean (SD)2 0.78 (0.36) 1.03 (0.43) 0.043
6 weeks’ post-stroke
Berg Balance Scale (n/29) (n/29)
Mean (SD) 33.9 (21.6) 35.4 (21.1)
Median (IQR)1 46.0 (8.051.5) 42.0 (17.554.5) 0.464
Fast walking speed (m/s) (n/21) (n/24)
Mean (SD)2 0.91 (0.31) 1.06 (0.46) 0.217
26 weeks’ post-stroke
Berg Balance Scale (n/23) (n/28)
Mean (SD) 35.7 (20.6) 36.3 (20.2)
Median (IQR)1 44.0 (19.053.0) 43.5 (23.055.0) 0.842
Fast walking speed (m/s) (n/18) (n/22)
Mean (SD)2 1.02 (0.41) 1.15 (0.53) 0.406
52 weeks’ post-stroke
Berg Balance Scale (n/23) (n/23)
Mean (SD) 33.1 (22.1) 36.0 (22.1)
Median (IQR)1 43.0 (6.053.0) 45.0 (13.056.0) 0.440
Fast walking speed (m/s) (n/15) (n/18)
Mean (SD)2 0.97 (0.41) 1.22 (0.48) 0.130
ESUS/extended stroke unit service; OSUS/ordinary stroke unit service; IQR/inter quartile range; SD/standard deviation; 1 Mann-
Whitney U test; 2 Student’s t -test.
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Although ESD trials seems to be beneficial for long-term
dependency (9), it is still unknown which factors are the most
efficient. In this study we focus on the early exercise therapy in
the patient’s home. Regarding dependency we suggest that the
functional level can improve both by improvements in body
function and by adjustment of the facilities. Improvement in
balance measured by the BBS is most likely dependent on
improvement within the body systems.
To our knowledge this is the first ESD trial reporting results
on the BBS, while 3 other studies have reported walking speed
(2629), The results from those studies support our finding
showing no difference in walking speed between the extended
service and the ordinary service group. There could be at least 4
reasons for this result. In the first place both groups received
stroke unit treatment which improves functional outcome (1, 2,
20) and makes it challenging to achieve further improvement.
Secondly, we have not registered the content in detail and
cannot be sure if the exercises were as task-specific and
functional as intended, even though they were conducted in
the patients’ homes. Thirdly, the intensity of the exercise therapy
may have been too low to give any additional effect. The fourth
and last reason could be the additional emphasis on home
safety intervention which may result in less challenge to the
balance system and less improvement in balance and walking
speed.
When each time point is analysed separately, the measure-
ments will be from different subjects. It is of primary interest to
analyse how subjects respond over time. The analysis of change
within the 2 groups on those patients who are available through
the whole study shows a significant improvement on BBS from
1 to 6 weeks’ follow-up and from 1 to 26 weeks’ follow-up in the
extended service group. It also shows an improvement on fast
Table III. Changes within groups during follow-up on those patients who completed all assessments on Berg Balance Scale (BBS) and fast walking
speed
ESUS OSUS
n Median (IQR)
Change within
group p -value1 n Median (IQR)
Change within
group p -value1
BBS
1 week 23 38.0 (951) 23 50.0 (2055)
6 weeks 23 47.0 (953) 0.013 23 53.0 (1556) 0.815
26 weeks 23 44.0 (1953) 0.051 23 48.0 (2356) 0.897
52 weeks 23 43.0 (653) 0.824 23 45.0 (1356) 0.505
n Mean (SD)
Change within
group p -value2 n Mean (SD)
Change within
group p -value2
Fast walking
speed (m/s)
1 week 14 0.89 (0.35) 17 1.15 (0.39)
6 weeks 14 1.05 (0.26) 0.022 17 1.21 (0.42) 0.287
26 weeks 14 1.11 (0.42) 0.044 17 1.28 (0.51) 0.122
52 weeks 14 1.02 (0.38) 0.028 17 1.23 (0.50) 0.243
ESUS/extended stroke unit service; OSUS/ordinary stroke unit service; IQR/inter quartile range; SD/standard deviation; 1Wilcoxon
signed rank test; 2Paired t -test; Change within group is change from 1 to 6 weeks, from 1 to 26 weeks and from 1 to 52 weeks.
Fig. 2. How patients who have completed all assessments
on Berg Balance Scale (BBS) respond over time.
*Difference in change between groups from 1 week
follow-up to 6 weeks’ follow-up (p/0.065). $Difference
in change between groups from 1 week follow-up to 26
weeks’ follow-up (p/0.142). %Difference in change
between groups from 1 week follow-up to 52 weeks’
follow-up (p/0.400). ESUS/extended stroke unit ser-
vice; OSUS/ordinary stroke unit service.
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walking speed from 1 to 6 weeks’ follow-up, from 1 to 26 weeks’
follow-up and from 1 to 52 weeks’ follow-up. There were no
similar improvements in the ordinary service group. One
possible reason for no significant improvement from 1 to 6
weeks’ follow-up in the ordinary service group may be due to
the fact that this group was already close to the ceiling effect on
BBS at 1 week follow-up.
When analysing the differences in change between the 2
groups from 1 week follow-up to each time point we found an
almost significant greater improvement (p/0.065) in the
extended service group compared with the ordinary service
group the first 6 weeks after the stroke and a trend toward
greater improvement from 1 to 26 weeks (p/0.142). This
improvement might indicate that the extended service group is
safer during transfer situations and consequently has reduced
risk of falling, although these differences were not confirmed by
the fast walking speed, and the trend toward greater improve-
ment on BBS in the extended service group may also be due to
the ceiling effect on BBS in the ordinary service group.
However, it is difficult to make a final conclusion about the
clinical relevance of this result because of the number of subjects
is too small.
The visual analysis of Figs. 2 and 3 also shows an initial
improvement and further decline in both balance and fast
walking speed. This initial improvement and long-term decline
in functional outcome and balance is confirmed by Langhammer
& Stanghelle (30) in their study comparing Bobath treatment
with a motor relearning programme.
Although the OR for poor balance could not be calculated for
those with initial severe leg paresis, we will propose there is a
strong association between those 2 variables. This result is in
contrast to another study which found no association between leg
paresis and falling when the results were adjusted for depression
(3). One possible reason for this is the different ways of
categorizing the leg item and the adjustment of different
confounders. The Copenhagen Stroke Study has documented a
strong relationship between initial leg paresis and recovery of
walking function (14). Balance is an important component of
walking function and this study supports our findings showing
an association between initial severe leg paresis and poor balance.
Table IV. Odds ratio (OR) and 95% confidence interval (CI) for poor balance one year after stroke associated with measures of initial leg paresis
and initial movement ability
Variable
Stroke patients
(n )
Cases with BBSB/45
(n ) OR (95% CI)a p-valuea
SSS leg score
No paresis 11 4 1.0
Moderate paresis 31 15 1.5 (0.37.3) 0.581
Severe paresis 4 4 nc
SSS movement score
Independent walking ability 15 3 1.0
Walks with support 20 10 4.6 (0.826.5) 0.085
No walking ability 11 10 42.1 (3.5513.9) 0.003
aOR adjusted for age, sex, treatment group and number of days from onset of symptoms to hospital admission; nc/not calculated because
there were no cases with good balance; SSS/Scandinavian Stroke Scale; BBS/Berg Balance Scale.
Fig. 3. How patients who have completed all assessments
on fast walking speed respond over time. *Difference in
change between groups from 1 week follow-up to 6
weeks’ follow-up (p/0.224). $Difference in change
between groups from 1 week follow-up to 26 weeks’
follow-up (p/0.494). %Difference in change between
groups from 1 week follow-up to 52 weeks’ follow-up
(p/0.557). ESUS/extended stroke unit service;
OSUS/ordinary stroke unit service.
0
0,2
0,4
0,6
0,8
1
1,2
1,4
one week six weeks twenty-six weeks fifty-two weeks
M
ea
n 
w
al
ki
ng
 s
pe
ed
 (m
/s)
    
   
ESUS, (n=14)
OSUS, (n=17)
*
† ‡
Effect of early supported discharge on balance and walking speed 373
J Rehabil Med 38
The ability to move depends on trunk control and the strong
association between early inability to move and poor balance
after one year is confirmed by other studies that identify trunk
control as en early predictor of functional outcome after stroke
(3133).
The results of this study of ESD with early rehabilitation in
the patient’s home does not conclusively indicate that ESD has
an effect on balance. In addition, a strong association was found
between initial severe leg paresis, initial inability to walk and
poor balance after one year.
Further research should emphasize task-specific exercise
therapy with a higher intensity in addition to ESD to enhance
further improvement on balance and walking speed in order to
facilitate an active life for the stroke patients.
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